{
  "metadata": {
    "graph_path": "./logic_graph.png",
    "num_solutions": 10,
    "family_stats": {
      "1": {
        "core": 1,
        "branch": 4
      },
      "2": {
        "core": 1,
        "branch": 0
      },
      "3": {
        "core": 1,
        "branch": 1
      },
      "4": {
        "core": 1,
        "branch": 0
      },
      "5": {
        "core": 1,
        "branch": 0
      }
    }
  },
  "knowledge_base": {
    "rules": [
      {
        "id": "Rule1",
        "formal": "(A1 → G)",
        "prover9_expression": "(develops_cure(CompanyX, DiseaseAlpha) -> successful_treatment(DiseaseAlpha))",
        "natural": "If CompanyX develops a cure for DiseaseAlpha, then DiseaseAlpha has a successful treatment."
      },
      {
        "id": "Rule2",
        "formal": "(A11 → ¬A10)",
        "prover9_expression": "(publishes_paper(ResearcherA, JournalScience) -> -experiences_setback(CompanyX, ClinicalTrial))",
        "natural": "Provided that ResearcherA publishes a paper in JournalScience, it is not the case that CompanyX experiences a setback in a clinical trial."
      },
      {
        "id": "Rule3",
        "formal": "(A12 ∨ A11)",
        "prover9_expression": "(publishes_paper(ResearcherB, JournalNature) | publishes_paper(ResearcherA, JournalScience))",
        "natural": "ResearcherB publishes a paper in JournalNature or ResearcherA publishes a paper in JournalScience."
      },
      {
        "id": "Rule4",
        "formal": "(A13 → ¬A12)",
        "prover9_expression": "(discovers_mechanism(ResearcherA, SubstanceGamma) -> -publishes_paper(ResearcherB, JournalNature))",
        "natural": "Whenever ResearcherA discovers the mechanism of SubstanceGamma, ResearcherB does not publish a paper in JournalNature."
      },
      {
        "id": "Rule5",
        "formal": "(A14 → A15)",
        "prover9_expression": "(develops_resistance(DiseaseAlpha, TreatmentBeta) -> requires_new_treatment(DiseaseAlpha))",
        "natural": "If DiseaseAlpha develops resistance to TreatmentBeta, it requires a new treatment."
      },
      {
        "id": "Rule6",
        "formal": "(A16 → G)",
        "prover9_expression": "(secures_patent(CompanyX, SubstanceGamma) -> successful_treatment(DiseaseAlpha))",
        "natural": "Under the condition that CompanyX secures a patent for SubstanceGamma, DiseaseAlpha has a successful treatment."
      },
      {
        "id": "Rule7",
        "formal": "(A17 → A18)",
        "prover9_expression": "(licenses_technology(CompanyY, CompanyX) -> shares_intellectual_property(CompanyX, CompanyY))",
        "natural": "If CompanyY licenses technology from CompanyX, then CompanyX shares intellectual property with CompanyY."
      },
      {
        "id": "Rule8",
        "formal": "(A19 → ¬A18)",
        "prover9_expression": "(protects_patent(CompanyX) -> -shares_intellectual_property(CompanyX, CompanyY))",
        "natural": "Provided that CompanyX protects its patent, it is not the case that CompanyX shares intellectual property with CompanyY."
      },
      {
        "id": "Rule9",
        "formal": "(A2 → G)",
        "prover9_expression": "(develops_cure(CompanyY, DiseaseAlpha) -> successful_treatment(DiseaseAlpha))",
        "natural": "If CompanyY develops a cure for DiseaseAlpha, then DiseaseAlpha has a successful treatment."
      },
      {
        "id": "Rule10",
        "formal": "(A22 → ¬A21)",
        "prover9_expression": "(receives_award(ResearcherA) -> -receives_recognition(ResearcherA))",
        "natural": "Whenever ResearcherA receives an award, ResearcherA does not receive recognition."
      },
      {
        "id": "Rule11",
        "formal": "(A23 ∨ (¬(A20 ∨ G) → A22))",
        "prover9_expression": "(collaborates(ResearcherA, ResearcherB) | (-(achieves_breakthrough(ResearcherA) | successful_treatment(DiseaseAlpha)) -> receives_award(ResearcherA)))",
        "natural": "ResearcherA collaborates with ResearcherB or, if neither ResearcherA achieves a breakthrough nor DiseaseAlpha has a successful treatment, ResearcherA receives an award."
      },
      {
        "id": "Rule12",
        "formal": "(A24 → G)",
        "prover9_expression": "(completes_study(InstituteM, SubstanceGamma) -> successful_treatment(DiseaseAlpha))",
        "natural": "If InstituteM completes a study on SubstanceGamma, then DiseaseAlpha has a successful treatment."
      },
      {
        "id": "Rule13",
        "formal": "(A25 → G)",
        "prover9_expression": "(completes_study(InstituteN, SubstanceGamma) -> successful_treatment(DiseaseAlpha))",
        "natural": "Under the condition that InstituteN completes a study on SubstanceGamma, DiseaseAlpha has a successful treatment."
      },
      {
        "id": "Rule14",
        "formal": "(A26 → A24)",
        "prover9_expression": "(initiates_trial(InstituteM, DiseaseAlpha) -> completes_study(InstituteM, SubstanceGamma))",
        "natural": "If InstituteM initiates a trial for DiseaseAlpha, then InstituteM completes a study on SubstanceGamma."
      },
      {
        "id": "Rule15",
        "formal": "(A27 → A25)",
        "prover9_expression": "(initiates_trial(InstituteN, DiseaseAlpha) -> completes_study(InstituteN, SubstanceGamma))",
        "natural": "Provided that InstituteN initiates a trial for DiseaseAlpha, InstituteN completes a study on SubstanceGamma."
      },
      {
        "id": "Rule16",
        "formal": "(A28 → A26)",
        "prover9_expression": "(obtains_ethics_approval(InstituteM) -> initiates_trial(InstituteM, DiseaseAlpha))",
        "natural": "If InstituteM obtains ethics approval, then InstituteM initiates a trial for DiseaseAlpha."
      },
      {
        "id": "Rule17",
        "formal": "(A28 ∨ A29)",
        "prover9_expression": "(obtains_ethics_approval(InstituteM) | obtains_ethics_approval(InstituteN))",
        "natural": "InstituteM obtains ethics approval or InstituteN obtains ethics approval."
      },
      {
        "id": "Rule18",
        "formal": "(A3 ∨ A4)",
        "prover9_expression": "(conducts_research(CompanyX, SubstanceGamma) | conducts_research(CompanyY, SubstanceGamma))",
        "natural": "Either CompanyX conducts research on SubstanceGamma or CompanyY conducts research on SubstanceGamma."
      },
      {
        "id": "Rule19",
        "formal": "(A31 → ¬A30)",
        "prover9_expression": "(violates_protocol(ResearcherC) -> -faces_ethical_issues(InstituteM))",
        "natural": "Whenever ResearcherC violates protocol, InstituteM does not face ethical issues."
      },
      {
        "id": "Rule20",
        "formal": "(A31 ∨ A32)",
        "prover9_expression": "(violates_protocol(ResearcherC) | violates_protocol(ResearcherD))",
        "natural": "ResearcherC violates protocol or ResearcherD violates protocol."
      },
      {
        "id": "Rule21",
        "formal": "(A32 → ¬A30)",
        "prover9_expression": "(violates_protocol(ResearcherD) -> -faces_ethical_issues(InstituteM))",
        "natural": "If ResearcherD violates protocol, then InstituteM does not face ethical issues."
      },
      {
        "id": "Rule22",
        "formal": "(A33 → A34)",
        "prover9_expression": "(shows_efficacy(SubstanceGamma, DiseaseAlpha) -> shows_toxicity(SubstanceGamma))",
        "natural": "Provided that SubstanceGamma shows efficacy against DiseaseAlpha, it shows toxicity."
      },
      {
        "id": "Rule23",
        "formal": "(A33 ∨ ¬A5)",
        "prover9_expression": "(shows_efficacy(SubstanceGamma, DiseaseAlpha) | -receives_funding(CompanyX, GrantOne))",
        "natural": "SubstanceGamma shows efficacy against DiseaseAlpha or CompanyX does not receive funding from GrantOne."
      },
      {
        "id": "Rule24",
        "formal": "(A34 → A35)",
        "prover9_expression": "(shows_toxicity(SubstanceGamma) -> passes_safety_test(SubstanceGamma))",
        "natural": "If SubstanceGamma shows toxicity, then it passes a safety test."
      },
      {
        "id": "Rule25",
        "formal": "(A34 → ¬A35)",
        "prover9_expression": "(shows_toxicity(SubstanceGamma) -> -passes_safety_test(SubstanceGamma))",
        "natural": "Under the condition that SubstanceGamma shows toxicity, it does not pass a safety test."
      },
      {
        "id": "Rule26",
        "formal": "(A36 → A6)",
        "prover9_expression": "(conducts_preclinical(CompanyX, SubstanceGamma) -> receives_funding(CompanyY, GrantOne))",
        "natural": "If CompanyX conducts preclinical studies on SubstanceGamma, then CompanyY receives funding from GrantOne."
      },
      {
        "id": "Rule27",
        "formal": "(A37 → ¬A5)",
        "prover9_expression": "(conducts_preclinical(CompanyY, SubstanceGamma) -> -receives_funding(CompanyX, GrantOne))",
        "natural": "Provided that CompanyY conducts preclinical studies on SubstanceGamma, CompanyX does not receive funding from GrantOne."
      },
      {
        "id": "Rule28",
        "formal": "(A4 → A2)",
        "prover9_expression": "(conducts_research(CompanyY, SubstanceGamma) -> develops_cure(CompanyY, DiseaseAlpha))",
        "natural": "If CompanyY conducts research on SubstanceGamma, then CompanyY develops a cure for DiseaseAlpha."
      },
      {
        "id": "Rule29",
        "formal": "(A40 ∨ (A39 → A38))",
        "prover9_expression": "(continues_research(CompanyX) | (halts_development(CompanyY, SubstanceGamma) -> halts_development(CompanyX, SubstanceGamma)))",
        "natural": "CompanyX continues research or, if CompanyY halts development of SubstanceGamma, then CompanyX halts development of SubstanceGamma."
      },
      {
        "id": "Rule30",
        "formal": "(A41 ∨ ¬A40)",
        "prover9_expression": "(continues_research(CompanyY) | -continues_research(CompanyX))",
        "natural": "CompanyY continues research or CompanyX does not continue research."
      },
      {
        "id": "Rule31",
        "formal": "(A49 → ¬A8)",
        "prover9_expression": "(withdraws_application(CompanyZ, FDA) -> -receives_approval(CompanyZ, FDA))",
        "natural": "If CompanyZ withdraws its application from the FDA, then CompanyZ does not receive approval from the FDA."
      },
      {
        "id": "Rule32",
        "formal": "(A5 ∨ (A3 → A1))",
        "prover9_expression": "(receives_funding(CompanyX, GrantOne) | (conducts_research(CompanyX, SubstanceGamma) -> develops_cure(CompanyX, DiseaseAlpha)))",
        "natural": "CompanyX receives funding from GrantOne or, if CompanyX conducts research on SubstanceGamma, then CompanyX develops a cure for DiseaseAlpha."
      },
      {
        "id": "Rule33",
        "formal": "(A50 → ¬A8)",
        "prover9_expression": "(withdraws_application(CompanyW, FDA) -> -receives_approval(CompanyZ, FDA))",
        "natural": "Provided that CompanyW withdraws its application from the FDA, CompanyZ does not receive approval from the FDA."
      },
      {
        "id": "Rule34",
        "formal": "(A51 → A49)",
        "prover9_expression": "(faces_regulatory_hurdles(CompanyZ) -> withdraws_application(CompanyZ, FDA))",
        "natural": "If CompanyZ faces regulatory hurdles, then CompanyZ withdraws its application from the FDA."
      },
      {
        "id": "Rule35",
        "formal": "(A51 ∨ A52)",
        "prover9_expression": "(faces_regulatory_hurdles(CompanyZ) | faces_regulatory_hurdles(CompanyW))",
        "natural": "CompanyZ faces regulatory hurdles or CompanyW faces regulatory hurdles."
      },
      {
        "id": "Rule36",
        "formal": "(A52 → A53)",
        "prover9_expression": "(faces_regulatory_hurdles(CompanyW) -> encounters_compliance_issues(CompanyZ))",
        "natural": "If CompanyW faces regulatory hurdles, then CompanyZ encounters compliance issues."
      },
      {
        "id": "Rule37",
        "formal": "(A53 → A54)",
        "prover9_expression": "(encounters_compliance_issues(CompanyZ) -> encounters_compliance_issues(CompanyW))",
        "natural": "Whenever CompanyZ encounters compliance issues, CompanyW encounters compliance issues."
      },
      {
        "id": "Rule38",
        "formal": "(A54 → A50)",
        "prover9_expression": "(encounters_compliance_issues(CompanyW) -> withdraws_application(CompanyW, FDA))",
        "natural": "Provided that CompanyW encounters compliance issues, CompanyW withdraws its application from the FDA."
      },
      {
        "id": "Rule39",
        "formal": "(A55 → ¬A17)",
        "prover9_expression": "(challenges_patent(CompanyY, CompanyX) -> -licenses_technology(CompanyY, CompanyX))",
        "natural": "If CompanyY challenges CompanyX's patent, then CompanyY does not license technology from CompanyX."
      },
      {
        "id": "Rule40",
        "formal": "(A55 ∨ A56)",
        "prover9_expression": "(challenges_patent(CompanyY, CompanyX) | challenges_patent(CompanyZ, CompanyX))",
        "natural": "CompanyY challenges CompanyX's patent or CompanyZ challenges CompanyX's patent."
      },
      {
        "id": "Rule41",
        "formal": "(A59 → (¬(¬(A56 → ¬A17) → ¬A57) → A58))",
        "prover9_expression": "(appeals_decision(CompanyY) -> (-(-(challenges_patent(CompanyZ, CompanyX) -> -licenses_technology(CompanyY, CompanyX)) -> -loses_lawsuit(CompanyY)) -> wins_lawsuit(CompanyX)))",
        "natural": "If CompanyY appeals the decision, then, if it is not the case that CompanyZ challenging CompanyX's patent implies that CompanyY does not license technology from CompanyX, then CompanyX wins a lawsuit."
      },
      {
        "id": "Rule42",
        "formal": "(A60 → (¬(¬(A56 → ¬A17) → ¬A57) → A58))",
        "prover9_expression": "(appeals_decision(CompanyZ) -> (-(-(challenges_patent(CompanyZ, CompanyX) -> -licenses_technology(CompanyY, CompanyX)) -> -loses_lawsuit(CompanyY)) -> wins_lawsuit(CompanyX)))",
        "natural": "If CompanyZ appeals the decision, then, provided that it is not the case that CompanyZ challenging CompanyX's patent implies that CompanyY does not license technology from CompanyX, then CompanyX wins a lawsuit."
      },
      {
        "id": "Rule43",
        "formal": "(A7 → (A6 ∨ ¬A5))",
        "prover9_expression": "(applies_for_grant(CompanyZ, GrantOne) -> (receives_funding(CompanyY, GrantOne) | -receives_funding(CompanyX, GrantOne)))",
        "natural": "Under the condition that CompanyZ applies for GrantOne, CompanyY receives funding from GrantOne or CompanyX does not receive funding from GrantOne."
      },
      {
        "id": "Rule44",
        "formal": "(A8 ∨ A7)",
        "prover9_expression": "(receives_approval(CompanyZ, FDA) | applies_for_grant(CompanyZ, GrantOne))",
        "natural": "CompanyZ receives approval from the FDA or CompanyZ applies for GrantOne."
      },
      {
        "id": "Rule45",
        "formal": "(A9 ∨ ¬A8)",
        "prover9_expression": "(submits_application(CompanyZ, FDA) | -receives_approval(CompanyZ, FDA))",
        "natural": "CompanyZ submits an application to the FDA or CompanyZ does not receive approval from the FDA."
      },
      {
        "id": "Rule46",
        "formal": "(¬(A1 ∨ A2) → A43)",
        "prover9_expression": "(-(develops_cure(CompanyX, DiseaseAlpha) | develops_cure(CompanyY, DiseaseAlpha)) -> forms_consortium(CompanyY, CompanyX))",
        "natural": "Provided that it is not the case that either CompanyX develops a cure for DiseaseAlpha or CompanyY develops a cure for DiseaseAlpha, CompanyY forms a consortium with CompanyX."
      },
      {
        "id": "Rule47",
        "formal": "(¬(A1 ∨ A2) → ¬A42)",
        "prover9_expression": "(-(develops_cure(CompanyX, DiseaseAlpha) | develops_cure(CompanyY, DiseaseAlpha)) -> -forms_consortium(CompanyX, CompanyY))",
        "natural": "If it is not the case that either CompanyX develops a cure for DiseaseAlpha or CompanyY develops a cure for DiseaseAlpha, then CompanyX does not form a consortium with CompanyY."
      },
      {
        "id": "Rule48",
        "formal": "(¬(A20 ∨ G) → A21)",
        "prover9_expression": "(-(achieves_breakthrough(ResearcherA) | successful_treatment(DiseaseAlpha)) -> receives_recognition(ResearcherA))",
        "natural": "Under the condition that it is not the case that either ResearcherA achieves a breakthrough or DiseaseAlpha has a successful treatment, ResearcherA receives recognition."
      },
      {
        "id": "Rule49",
        "formal": "(¬(A29 → A27) → A30)",
        "prover9_expression": "(-(obtains_ethics_approval(InstituteN) -> initiates_trial(InstituteN, DiseaseAlpha)) -> faces_ethical_issues(InstituteM))",
        "natural": "If it is not the case that InstituteN obtaining ethics approval implies that InstituteN initiates a trial for DiseaseAlpha, then InstituteM faces ethical issues."
      },
      {
        "id": "Rule50",
        "formal": "(¬(A36 ∨ A37) → A39)",
        "prover9_expression": "(-(conducts_preclinical(CompanyX, SubstanceGamma) | conducts_preclinical(CompanyY, SubstanceGamma)) -> halts_development(CompanyY, SubstanceGamma))",
        "natural": "If it is not the case that either CompanyX conducts preclinical studies on SubstanceGamma or CompanyY conducts preclinical studies on SubstanceGamma, then CompanyY halts development of SubstanceGamma."
      },
      {
        "id": "Rule51",
        "formal": "(¬(A43 → A42) → A44)",
        "prover9_expression": "(-(forms_consortium(CompanyY, CompanyX) -> forms_consortium(CompanyX, CompanyY)) -> dissolves_partnership(CompanyX, CompanyY))",
        "natural": "Provided that it is not the case that CompanyY forming a consortium with CompanyX implies that CompanyX forms a consortium with CompanyY, CompanyX dissolves its partnership with CompanyY."
      },
      {
        "id": "Rule52",
        "formal": "(¬(A43 → A42) → A45)",
        "prover9_expression": "(-(forms_consortium(CompanyY, CompanyX) -> forms_consortium(CompanyX, CompanyY)) -> dissolves_partnership(CompanyY, CompanyX))",
        "natural": "If it is not the case that CompanyY forming a consortium with CompanyX implies that CompanyX forms a consortium with CompanyY, then CompanyY dissolves its partnership with CompanyX."
      },
      {
        "id": "Rule53",
        "formal": "(¬(A45 → ¬A44) → ¬A46)",
        "prover9_expression": "(-(dissolves_partnership(CompanyY, CompanyX) -> -dissolves_partnership(CompanyX, CompanyY)) -> -seeks_mediation(CompanyX, CompanyY))",
        "natural": "Provided that it is not the case that CompanyY dissolving its partnership with CompanyX implies that CompanyX does not dissolve its partnership with CompanyY, CompanyX does not seek mediation with CompanyY."
      },
      {
        "id": "Rule54",
        "formal": "(¬(A56 → ¬A17) → A57)",
        "prover9_expression": "(-(challenges_patent(CompanyZ, CompanyX) -> -licenses_technology(CompanyY, CompanyX)) -> loses_lawsuit(CompanyY))",
        "natural": "Under the condition that it is not the case that CompanyZ challenging CompanyX's patent implies that CompanyY does not license technology from CompanyX, CompanyY loses a lawsuit."
      },
      {
        "id": "Rule55",
        "formal": "(¬(A59 ∨ A60) → A61)",
        "prover9_expression": "(-(appeals_decision(CompanyY) | appeals_decision(CompanyZ)) -> accepts_ruling(CompanyY))",
        "natural": "Provided that it is not the case that either CompanyY appeals the decision or CompanyZ appeals the decision, CompanyY accepts the ruling."
      },
      {
        "id": "Rule56",
        "formal": "(¬(A59 ∨ A60) → ¬A61)",
        "prover9_expression": "(-(appeals_decision(CompanyY) | appeals_decision(CompanyZ)) -> -accepts_ruling(CompanyY))",
        "natural": "If it is not the case that either CompanyY appeals the decision or CompanyZ appeals the decision, then CompanyY does not accept the ruling."
      },
      {
        "id": "Rule57",
        "formal": "(¬(¬(A45 → ¬A44) → A46) → A47)",
        "prover9_expression": "(-(-(dissolves_partnership(CompanyY, CompanyX) -> -dissolves_partnership(CompanyX, CompanyY)) -> seeks_mediation(CompanyX, CompanyY)) -> reaches_settlement(CompanyX, CompanyY))",
        "natural": "Under the condition that it is not the case that CompanyY dissolving its partnership with CompanyX not implying that CompanyX does not dissolve its partnership with CompanyY implies that CompanyX seeks mediation with CompanyY, CompanyX and CompanyY reach a settlement."
      },
      {
        "id": "Rule58",
        "formal": "(¬(¬(A56 → ¬A17) → ¬A57) → ¬A58)",
        "prover9_expression": "(-(-(challenges_patent(CompanyZ, CompanyX) -> -licenses_technology(CompanyY, CompanyX)) -> -loses_lawsuit(CompanyY)) -> -wins_lawsuit(CompanyX))",
        "natural": "Under the condition that it is not the case that CompanyZ challenging CompanyX's patent not implying that CompanyY does not license technology from CompanyX implies that CompanyY does not lose a lawsuit, CompanyX does not win a lawsuit."
      },
      {
        "id": "Rule59",
        "formal": "(¬(¬(¬(A45 → ¬A44) → A46) → ¬A47) → A48)",
        "prover9_expression": "(-(-(-(dissolves_partnership(CompanyY, CompanyX) -> -dissolves_partnership(CompanyX, CompanyY)) -> seeks_mediation(CompanyX, CompanyY)) -> -reaches_settlement(CompanyX, CompanyY)) -> renews_collaboration(CompanyX, CompanyY))",
        "natural": "If it is not the case that CompanyY dissolving its partnership with CompanyX not implying that CompanyX does not dissolve its partnership with CompanyY not implying that CompanyX seeks mediation with CompanyY implies that CompanyX and CompanyY do not reach a settlement, then CompanyX renews collaboration with CompanyY."
      },
      {
        "id": "Rule60",
        "formal": "(¬A13 → A14)",
        "prover9_expression": "(-discovers_mechanism(ResearcherA, SubstanceGamma) -> develops_resistance(DiseaseAlpha, TreatmentBeta))",
        "natural": "If ResearcherA does not discover the mechanism of SubstanceGamma, then DiseaseAlpha develops resistance to TreatmentBeta."
      },
      {
        "id": "Rule61",
        "formal": "(¬A16 → A17)",
        "prover9_expression": "(-secures_patent(CompanyX, SubstanceGamma) -> licenses_technology(CompanyY, CompanyX))",
        "natural": "Under the condition that CompanyX does not secure a patent for SubstanceGamma, CompanyY licenses technology from CompanyX."
      },
      {
        "id": "Rule62",
        "formal": "(¬G → A10)",
        "prover9_expression": "(-successful_treatment(DiseaseAlpha) -> experiences_setback(CompanyX, ClinicalTrial))",
        "natural": "Provided that DiseaseAlpha does not have a successful treatment, CompanyX experiences a setback in a clinical trial."
      }
    ],
    "facts": [
      {
        "id": "Fact1",
        "formal": "A19",
        "prover9_expression": "protects_patent(CompanyX)",
        "natural": "CompanyX protects its patent."
      },
      {
        "id": "Fact2",
        "formal": "¬A15",
        "prover9_expression": "-requires_new_treatment(DiseaseAlpha)",
        "natural": "DiseaseAlpha does not require a new treatment."
      },
      {
        "id": "Fact3",
        "formal": "¬A20",
        "prover9_expression": "-achieves_breakthrough(ResearcherA)",
        "natural": "ResearcherA does not achieve a breakthrough."
      },
      {
        "id": "Fact4",
        "formal": "¬A23",
        "prover9_expression": "-collaborates(ResearcherA, ResearcherB)",
        "natural": "ResearcherA does not collaborate with ResearcherB."
      },
      {
        "id": "Fact5",
        "formal": "¬A38",
        "prover9_expression": "-halts_development(CompanyX, SubstanceGamma)",
        "natural": "CompanyX does not halt development of SubstanceGamma."
      },
      {
        "id": "Fact6",
        "formal": "¬A41",
        "prover9_expression": "-continues_research(CompanyY)",
        "natural": "CompanyY does not continue research."
      },
      {
        "id": "Fact7",
        "formal": "¬A48",
        "prover9_expression": "-renews_collaboration(CompanyX, CompanyY)",
        "natural": "CompanyX does not renew collaboration with CompanyY."
      },
      {
        "id": "Fact8",
        "formal": "¬A6",
        "prover9_expression": "-receives_funding(CompanyY, GrantOne)",
        "natural": "CompanyY does not receive funding from GrantOne."
      },
      {
        "id": "Fact9",
        "formal": "¬A9",
        "prover9_expression": "-submits_application(CompanyZ, FDA)",
        "natural": "CompanyZ does not submit an application to the FDA."
      }
    ]
  },
  "target": {
    "formal": "G",
    "prover9": "G",
    "prover9_expression": "successful_treatment(DiseaseAlpha)",
    "natural": "DiseaseAlpha has a successful treatment."
  },
  "solutions": [
    {
      "id": 1,
      "family_id": 1,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DS",
          "premises_used": [
            "(A9 | -A8)",
            "-A9"
          ],
          "conclusion": "-A8",
          "natural": "CompanyZ does not receive approval from the FDA."
        },
        {
          "step_number": 2,
          "rule_applied": "DS",
          "premises_used": [
            "(A8 | A7)",
            "-A8"
          ],
          "conclusion": "A7",
          "natural": "CompanyZ applies for GrantOne."
        },
        {
          "step_number": 3,
          "rule_applied": "MP",
          "premises_used": [
            "(A7 -> (A6 | -A5))",
            "A7"
          ],
          "conclusion": "(A6 | -A5)",
          "natural": "CompanyY receives funding from GrantOne or CompanyX does not receive funding from GrantOne."
        },
        {
          "step_number": 4,
          "rule_applied": "DS",
          "premises_used": [
            "(A6 | -A5)",
            "-A6"
          ],
          "conclusion": "-A5",
          "natural": "CompanyX does not receive funding from GrantOne."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            "(A5 | (A3 -> A1))",
            "-A5"
          ],
          "conclusion": "(A3 -> A1)",
          "natural": "If CompanyX conducts research on SubstanceGamma, then CompanyX develops a cure for DiseaseAlpha."
        },
        {
          "step_number": 6,
          "rule_applied": "CD",
          "premises_used": [
            "(A3 -> A1)",
            "(A4 -> A2)",
            "(A3 | A4)"
          ],
          "conclusion": "(A1 | A2)",
          "natural": "Either CompanyX develops a cure for DiseaseAlpha or CompanyY develops a cure for DiseaseAlpha."
        },
        {
          "step_number": 7,
          "rule_applied": "DE",
          "premises_used": [
            "(A1 | A2)",
            "(A1 -> G)",
            "(A2 -> G)"
          ],
          "conclusion": "G",
          "natural": "DiseaseAlpha has a successful treatment."
        }
      ]
    },
    {
      "id": 2,
      "family_id": 2,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MT",
          "premises_used": [
            "(A14 -> A15)",
            "-A15"
          ],
          "conclusion": "-A14",
          "natural": "DiseaseAlpha does not develop resistance to TreatmentBeta."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            "(-A13 -> A14)",
            "-A14"
          ],
          "conclusion": "A13",
          "natural": "ResearcherA discovers the mechanism of SubstanceGamma."
        },
        {
          "step_number": 3,
          "rule_applied": "MP",
          "premises_used": [
            "(A13 -> -A12)",
            "A13"
          ],
          "conclusion": "-A12",
          "natural": "ResearcherB does not publish a paper in JournalNature."
        },
        {
          "step_number": 4,
          "rule_applied": "DS",
          "premises_used": [
            "(A12 | A11)",
            "-A12"
          ],
          "conclusion": "A11",
          "natural": "ResearcherA publishes a paper in JournalScience."
        },
        {
          "step_number": 5,
          "rule_applied": "MP",
          "premises_used": [
            "(A11 -> -A10)",
            "A11"
          ],
          "conclusion": "-A10",
          "natural": "CompanyX does not experience a setback in a clinical trial."
        },
        {
          "step_number": 6,
          "rule_applied": "MT",
          "premises_used": [
            "(-G -> A10)",
            "-A10"
          ],
          "conclusion": "G",
          "natural": "DiseaseAlpha has a successful treatment."
        }
      ]
    },
    {
      "id": 3,
      "family_id": 3,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MP",
          "premises_used": [
            "(A19 -> -A18)",
            "A19"
          ],
          "conclusion": "-A18",
          "natural": "CompanyX does not share intellectual property with CompanyY."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            "(A17 -> A18)",
            "-A18"
          ],
          "conclusion": "-A17",
          "natural": "CompanyY does not license technology from CompanyX."
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            "(-A16 -> A17)",
            "-A17"
          ],
          "conclusion": "A16",
          "natural": "CompanyX secures a patent for SubstanceGamma."
        },
        {
          "step_number": 4,
          "rule_applied": "MP",
          "premises_used": [
            "(A16 -> G)",
            "A16"
          ],
          "conclusion": "G",
          "natural": "DiseaseAlpha has a successful treatment."
        }
      ]
    },
    {
      "id": 4,
      "family_id": 4,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DS",
          "premises_used": [
            "(A23 | (-(A20 | G) -> A22))",
            "-A23"
          ],
          "conclusion": "(-(A20 | G) -> A22)",
          "natural": "If it is not the case that either ResearcherA achieves a breakthrough or DiseaseAlpha has a successful treatment, then ResearcherA receives an award."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(-(A20 | G) -> A22)",
            "(A22 -> -A21)"
          ],
          "conclusion": "(-(A20 | G) -> -A21)",
          "natural": "Provided that it is not the case that either ResearcherA achieves a breakthrough or DiseaseAlpha has a successful treatment, ResearcherA does not receive recognition."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A20 | G) -> A21)",
            "(-(A20 | G) -> -A21)"
          ],
          "conclusion": "(A20 | G)",
          "natural": "Either ResearcherA achieves a breakthrough or DiseaseAlpha has a successful treatment."
        },
        {
          "step_number": 4,
          "rule_applied": "DS",
          "premises_used": [
            "(A20 | G)",
            "-A20"
          ],
          "conclusion": "G",
          "natural": "DiseaseAlpha has a successful treatment."
        }
      ]
    },
    {
      "id": 5,
      "family_id": 5,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            "(A31 | A32)",
            "(A31 -> -A30)",
            "(A32 -> -A30)"
          ],
          "conclusion": "-A30",
          "natural": "InstituteM does not face ethical issues."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A29 -> A27) -> A30)",
            "-A30"
          ],
          "conclusion": "(A29 -> A27)",
          "natural": "Under the condition that InstituteN obtains ethics approval, InstituteN initiates a trial for DiseaseAlpha."
        },
        {
          "step_number": 3,
          "rule_applied": "CD",
          "premises_used": [
            "(A28 -> A26)",
            "(A29 -> A27)",
            "(A28 | A29)"
          ],
          "conclusion": "(A26 | A27)",
          "natural": "InstituteM initiates a trial for DiseaseAlpha or InstituteN initiates a trial for DiseaseAlpha."
        },
        {
          "step_number": 4,
          "rule_applied": "CD",
          "premises_used": [
            "(A26 -> A24)",
            "(A27 -> A25)",
            "(A26 | A27)"
          ],
          "conclusion": "(A24 | A25)",
          "natural": "InstituteM completes a study on SubstanceGamma or InstituteN completes a study on SubstanceGamma."
        },
        {
          "step_number": 5,
          "rule_applied": "DE",
          "premises_used": [
            "(A24 | A25)",
            "(A24 -> G)",
            "(A25 -> G)"
          ],
          "conclusion": "G",
          "natural": "DiseaseAlpha has a successful treatment."
        }
      ]
    },
    {
      "id": 6,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 3,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "RAA",
          "premises_used": [
            "(A34 -> A35)",
            "(A34 -> -A35)"
          ],
          "conclusion": "-A34",
          "natural": "SubstanceGamma does not show toxicity."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            "(A33 -> A34)",
            "-A34"
          ],
          "conclusion": "-A33",
          "natural": "SubstanceGamma does not show efficacy against DiseaseAlpha."
        },
        {
          "step_number": 3,
          "rule_applied": "DS",
          "premises_used": [
            "(A33 | -A5)",
            "-A33"
          ],
          "conclusion": "-A5",
          "natural": "CompanyX does not receive funding from GrantOne."
        },
        {
          "step_number": 4,
          "rule_applied": "DS",
          "premises_used": [
            "(A5 | (A3 -> A1))",
            "-A5"
          ],
          "conclusion": "(A3 -> A1)",
          "natural": "If CompanyX conducts research on SubstanceGamma, then CompanyX develops a cure for DiseaseAlpha."
        },
        {
          "step_number": 5,
          "rule_applied": "CD",
          "premises_used": [
            "(A3 -> A1)",
            "(A4 -> A2)",
            "(A3 | A4)"
          ],
          "conclusion": "(A1 | A2)",
          "natural": "Either CompanyX develops a cure for DiseaseAlpha or CompanyY develops a cure for DiseaseAlpha."
        },
        {
          "step_number": 6,
          "rule_applied": "DE",
          "premises_used": [
            "(A1 | A2)",
            "(A1 -> G)",
            "(A2 -> G)"
          ],
          "conclusion": "G",
          "natural": "DiseaseAlpha has a successful treatment."
        }
      ]
    },
    {
      "id": 7,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 2,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DS",
          "premises_used": [
            "(A41 | -A40)",
            "-A41"
          ],
          "conclusion": "-A40",
          "natural": "CompanyX does not continue research."
        },
        {
          "step_number": 2,
          "rule_applied": "DS",
          "premises_used": [
            "(A40 | (A39 -> A38))",
            "-A40"
          ],
          "conclusion": "(A39 -> A38)",
          "natural": "If CompanyY halts development of SubstanceGamma, then CompanyX halts development of SubstanceGamma."
        },
        {
          "step_number": 3,
          "rule_applied": "HS",
          "premises_used": [
            "(-(A36 | A37) -> A39)",
            "(A39 -> A38)"
          ],
          "conclusion": "(-(A36 | A37) -> A38)",
          "natural": "Under the condition that it is not the case that either CompanyX conducts preclinical studies on SubstanceGamma or CompanyY conducts preclinical studies on SubstanceGamma, CompanyX halts development of SubstanceGamma."
        },
        {
          "step_number": 4,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A36 | A37) -> A38)",
            "-A38"
          ],
          "conclusion": "(A36 | A37)",
          "natural": "CompanyX conducts preclinical studies on SubstanceGamma or CompanyY conducts preclinical studies on SubstanceGamma."
        },
        {
          "step_number": 5,
          "rule_applied": "CD",
          "premises_used": [
            "(A36 -> A6)",
            "(A37 -> -A5)",
            "(A36 | A37)"
          ],
          "conclusion": "(A6 | -A5)",
          "natural": "CompanyY receives funding from GrantOne or CompanyX does not receive funding from GrantOne."
        },
        {
          "step_number": 6,
          "rule_applied": "DS",
          "premises_used": [
            "(A6 | -A5)",
            "-A6"
          ],
          "conclusion": "-A5",
          "natural": "CompanyX does not receive funding from GrantOne."
        },
        {
          "step_number": 7,
          "rule_applied": "DS",
          "premises_used": [
            "(A5 | (A3 -> A1))",
            "-A5"
          ],
          "conclusion": "(A3 -> A1)",
          "natural": "If CompanyX conducts research on SubstanceGamma, then CompanyX develops a cure for DiseaseAlpha."
        },
        {
          "step_number": 8,
          "rule_applied": "CD",
          "premises_used": [
            "(A3 -> A1)",
            "(A4 -> A2)",
            "(A3 | A4)"
          ],
          "conclusion": "(A1 | A2)",
          "natural": "Either CompanyX develops a cure for DiseaseAlpha or CompanyY develops a cure for DiseaseAlpha."
        },
        {
          "step_number": 9,
          "rule_applied": "DE",
          "premises_used": [
            "(A1 | A2)",
            "(A1 -> G)",
            "(A2 -> G)"
          ],
          "conclusion": "G",
          "natural": "DiseaseAlpha has a successful treatment."
        }
      ]
    },
    {
      "id": 8,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 5,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MT",
          "premises_used": [
            "(-(-(-(A45 -> -A44) -> A46) -> -A47) -> A48)",
            "-A48"
          ],
          "conclusion": "(-(-(A45 -> -A44) -> A46) -> -A47)",
          "natural": "If it is not the case that CompanyY dissolving its partnership with CompanyX not implying that CompanyX does not dissolve its partnership with CompanyY implies that CompanyX seeks mediation with CompanyY, then CompanyX and CompanyY do not reach a settlement."
        },
        {
          "step_number": 2,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(-(A45 -> -A44) -> A46) -> A47)",
            "(-(-(A45 -> -A44) -> A46) -> -A47)"
          ],
          "conclusion": "(-(A45 -> -A44) -> A46)",
          "natural": "If it is not the case that CompanyY dissolving its partnership with CompanyX implies that CompanyX does not dissolve its partnership with CompanyY, then CompanyX seeks mediation with CompanyY."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A45 -> -A44) -> A46)",
            "(-(A45 -> -A44) -> -A46)"
          ],
          "conclusion": "(A45 -> -A44)",
          "natural": "Under the condition that CompanyY dissolves its partnership with CompanyX, CompanyX does not dissolve its partnership with CompanyY."
        },
        {
          "step_number": 4,
          "rule_applied": "HS",
          "premises_used": [
            "(-(A43 -> A42) -> A45)",
            "(A45 -> -A44)"
          ],
          "conclusion": "(-(A43 -> A42) -> -A44)",
          "natural": "Under the condition that it is not the case that CompanyY forming a consortium with CompanyX implies that CompanyX forms a consortium with CompanyY, CompanyX does not dissolve its partnership with CompanyY."
        },
        {
          "step_number": 5,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A43 -> A42) -> A44)",
            "(-(A43 -> A42) -> -A44)"
          ],
          "conclusion": "(A43 -> A42)",
          "natural": "If CompanyY forms a consortium with CompanyX, then CompanyX forms a consortium with CompanyY."
        },
        {
          "step_number": 6,
          "rule_applied": "HS",
          "premises_used": [
            "(-(A1 | A2) -> A43)",
            "(A43 -> A42)"
          ],
          "conclusion": "(-(A1 | A2) -> A42)",
          "natural": "If it is not the case that either CompanyX develops a cure for DiseaseAlpha or CompanyY develops a cure for DiseaseAlpha, then CompanyX forms a consortium with CompanyY."
        },
        {
          "step_number": 7,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A1 | A2) -> A42)",
            "(-(A1 | A2) -> -A42)"
          ],
          "conclusion": "(A1 | A2)",
          "natural": "Either CompanyX develops a cure for DiseaseAlpha or CompanyY develops a cure for DiseaseAlpha."
        },
        {
          "step_number": 8,
          "rule_applied": "DE",
          "premises_used": [
            "(A1 | A2)",
            "(A1 -> G)",
            "(A2 -> G)"
          ],
          "conclusion": "G",
          "natural": "DiseaseAlpha has a successful treatment."
        }
      ]
    },
    {
      "id": 9,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 0,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(A53 -> A54)",
            "(A54 -> A50)"
          ],
          "conclusion": "(A53 -> A50)",
          "natural": "If CompanyZ encounters compliance issues, then CompanyW withdraws its application from the FDA."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(A52 -> A53)",
            "(A53 -> A50)"
          ],
          "conclusion": "(A52 -> A50)",
          "natural": "Under the condition that CompanyW faces regulatory hurdles, CompanyW withdraws its application from the FDA."
        },
        {
          "step_number": 3,
          "rule_applied": "CD",
          "premises_used": [
            "(A51 -> A49)",
            "(A52 -> A50)",
            "(A51 | A52)"
          ],
          "conclusion": "(A49 | A50)",
          "natural": "CompanyZ withdraws its application from the FDA or CompanyW withdraws its application from the FDA."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            "(A49 | A50)",
            "(A49 -> -A8)",
            "(A50 -> -A8)"
          ],
          "conclusion": "-A8",
          "natural": "CompanyZ does not receive approval from the FDA."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            "(A8 | A7)",
            "-A8"
          ],
          "conclusion": "A7",
          "natural": "CompanyZ applies for GrantOne."
        },
        {
          "step_number": 6,
          "rule_applied": "MP",
          "premises_used": [
            "(A7 -> (A6 | -A5))",
            "A7"
          ],
          "conclusion": "(A6 | -A5)",
          "natural": "CompanyY receives funding from GrantOne or CompanyX does not receive funding from GrantOne."
        },
        {
          "step_number": 7,
          "rule_applied": "DS",
          "premises_used": [
            "(A6 | -A5)",
            "-A6"
          ],
          "conclusion": "-A5",
          "natural": "CompanyX does not receive funding from GrantOne."
        },
        {
          "step_number": 8,
          "rule_applied": "DS",
          "premises_used": [
            "(A5 | (A3 -> A1))",
            "-A5"
          ],
          "conclusion": "(A3 -> A1)",
          "natural": "If CompanyX conducts research on SubstanceGamma, then CompanyX develops a cure for DiseaseAlpha."
        },
        {
          "step_number": 9,
          "rule_applied": "CD",
          "premises_used": [
            "(A3 -> A1)",
            "(A4 -> A2)",
            "(A3 | A4)"
          ],
          "conclusion": "(A1 | A2)",
          "natural": "Either CompanyX develops a cure for DiseaseAlpha or CompanyY develops a cure for DiseaseAlpha."
        },
        {
          "step_number": 10,
          "rule_applied": "DE",
          "premises_used": [
            "(A1 | A2)",
            "(A1 -> G)",
            "(A2 -> G)"
          ],
          "conclusion": "G",
          "natural": "DiseaseAlpha has a successful treatment."
        }
      ]
    },
    {
      "id": 10,
      "family_id": 3,
      "path_type": "branch",
      "branch_from": 1,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A59 | A60) -> A61)",
            "(-(A59 | A60) -> -A61)"
          ],
          "conclusion": "(A59 | A60)",
          "natural": "CompanyY appeals the decision or CompanyZ appeals the decision."
        },
        {
          "step_number": 2,
          "rule_applied": "DE",
          "premises_used": [
            "(A59 | A60)",
            "(A59 -> (-(-(A56 -> -A17) -> -A57) -> A58))",
            "(A60 -> (-(-(A56 -> -A17) -> -A57) -> A58))"
          ],
          "conclusion": "(-(-(A56 -> -A17) -> -A57) -> A58)",
          "natural": "Provided that it is not the case that CompanyZ challenging CompanyX's patent not implying that CompanyY does not license technology from CompanyX implies that CompanyY does not lose a lawsuit, CompanyX wins a lawsuit."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(-(A56 -> -A17) -> -A57) -> A58)",
            "(-(-(A56 -> -A17) -> -A57) -> -A58)"
          ],
          "conclusion": "(-(A56 -> -A17) -> -A57)",
          "natural": "If it is not the case that CompanyZ challenging CompanyX's patent implies that CompanyY does not license technology from CompanyX, then CompanyY does not lose a lawsuit."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A56 -> -A17) -> A57)",
            "(-(A56 -> -A17) -> -A57)"
          ],
          "conclusion": "(A56 -> -A17)",
          "natural": "Under the condition that CompanyZ challenges CompanyX's patent, CompanyY does not license technology from CompanyX."
        },
        {
          "step_number": 5,
          "rule_applied": "DE",
          "premises_used": [
            "(A55 | A56)",
            "(A55 -> -A17)",
            "(A56 -> -A17)"
          ],
          "conclusion": "-A17",
          "natural": "CompanyY does not license technology from CompanyX."
        },
        {
          "step_number": 6,
          "rule_applied": "MT",
          "premises_used": [
            "(-A16 -> A17)",
            "-A17"
          ],
          "conclusion": "A16",
          "natural": "CompanyX secures a patent for SubstanceGamma."
        },
        {
          "step_number": 7,
          "rule_applied": "MP",
          "premises_used": [
            "(A16 -> G)",
            "A16"
          ],
          "conclusion": "G",
          "natural": "DiseaseAlpha has a successful treatment."
        }
      ]
    }
  ],
  "translations": {
    "domain_theme": "Pharmaceutical Research",
    "atomic_facts": {
      "A1": "develops_cure(CompanyX, DiseaseAlpha)",
      "A2": "develops_cure(CompanyY, DiseaseAlpha)",
      "A3": "conducts_research(CompanyX, SubstanceGamma)",
      "A4": "conducts_research(CompanyY, SubstanceGamma)",
      "A5": "receives_funding(CompanyX, GrantOne)",
      "A6": "receives_funding(CompanyY, GrantOne)",
      "A7": "applies_for_grant(CompanyZ, GrantOne)",
      "A8": "receives_approval(CompanyZ, FDA)",
      "A9": "submits_application(CompanyZ, FDA)",
      "A10": "experiences_setback(CompanyX, ClinicalTrial)",
      "A11": "publishes_paper(ResearcherA, JournalScience)",
      "A12": "publishes_paper(ResearcherB, JournalNature)",
      "A13": "discovers_mechanism(ResearcherA, SubstanceGamma)",
      "A14": "develops_resistance(DiseaseAlpha, TreatmentBeta)",
      "A15": "requires_new_treatment(DiseaseAlpha)",
      "A16": "secures_patent(CompanyX, SubstanceGamma)",
      "A17": "licenses_technology(CompanyY, CompanyX)",
      "A18": "shares_intellectual_property(CompanyX, CompanyY)",
      "A19": "protects_patent(CompanyX)",
      "A20": "achieves_breakthrough(ResearcherA)",
      "A21": "receives_recognition(ResearcherA)",
      "A22": "receives_award(ResearcherA)",
      "A23": "collaborates(ResearcherA, ResearcherB)",
      "A24": "completes_study(InstituteM, SubstanceGamma)",
      "A25": "completes_study(InstituteN, SubstanceGamma)",
      "A26": "initiates_trial(InstituteM, DiseaseAlpha)",
      "A27": "initiates_trial(InstituteN, DiseaseAlpha)",
      "A28": "obtains_ethics_approval(InstituteM)",
      "A29": "obtains_ethics_approval(InstituteN)",
      "A30": "faces_ethical_issues(InstituteM)",
      "A31": "violates_protocol(ResearcherC)",
      "A32": "violates_protocol(ResearcherD)",
      "A33": "shows_efficacy(SubstanceGamma, DiseaseAlpha)",
      "A34": "shows_toxicity(SubstanceGamma)",
      "A35": "passes_safety_test(SubstanceGamma)",
      "A36": "conducts_preclinical(CompanyX, SubstanceGamma)",
      "A37": "conducts_preclinical(CompanyY, SubstanceGamma)",
      "A38": "halts_development(CompanyX, SubstanceGamma)",
      "A39": "halts_development(CompanyY, SubstanceGamma)",
      "A40": "continues_research(CompanyX)",
      "A41": "continues_research(CompanyY)",
      "A42": "forms_consortium(CompanyX, CompanyY)",
      "A43": "forms_consortium(CompanyY, CompanyX)",
      "A44": "dissolves_partnership(CompanyX, CompanyY)",
      "A45": "dissolves_partnership(CompanyY, CompanyX)",
      "A46": "seeks_mediation(CompanyX, CompanyY)",
      "A47": "reaches_settlement(CompanyX, CompanyY)",
      "A48": "renews_collaboration(CompanyX, CompanyY)",
      "A49": "withdraws_application(CompanyZ, FDA)",
      "A50": "withdraws_application(CompanyW, FDA)",
      "A51": "faces_regulatory_hurdles(CompanyZ)",
      "A52": "faces_regulatory_hurdles(CompanyW)",
      "A53": "encounters_compliance_issues(CompanyZ)",
      "A54": "encounters_compliance_issues(CompanyW)",
      "A55": "challenges_patent(CompanyY, CompanyX)",
      "A56": "challenges_patent(CompanyZ, CompanyX)",
      "A57": "loses_lawsuit(CompanyY)",
      "A58": "wins_lawsuit(CompanyX)",
      "A59": "appeals_decision(CompanyY)",
      "A60": "appeals_decision(CompanyZ)",
      "A61": "accepts_ruling(CompanyY)",
      "G": "successful_treatment(DiseaseAlpha)"
    },
    "natural_facts": {
      "A1": "CompanyX develops a cure for DiseaseAlpha.",
      "A2": "CompanyY develops a cure for DiseaseAlpha.",
      "A3": "CompanyX conducts research on SubstanceGamma.",
      "A4": "CompanyY conducts research on SubstanceGamma.",
      "A5": "CompanyX receives funding from GrantOne.",
      "A6": "CompanyY receives funding from GrantOne.",
      "A7": "CompanyZ applies for GrantOne.",
      "A8": "CompanyZ receives approval from the FDA.",
      "A9": "CompanyZ submits an application to the FDA.",
      "A10": "CompanyX experiences a setback in a clinical trial.",
      "A11": "ResearcherA publishes a paper in JournalScience.",
      "A12": "ResearcherB publishes a paper in JournalNature.",
      "A13": "ResearcherA discovers the mechanism of SubstanceGamma.",
      "A14": "DiseaseAlpha develops resistance to TreatmentBeta.",
      "A15": "DiseaseAlpha requires a new treatment.",
      "A16": "CompanyX secures a patent for SubstanceGamma.",
      "A17": "CompanyY licenses technology from CompanyX.",
      "A18": "CompanyX shares intellectual property with CompanyY.",
      "A19": "CompanyX protects its patent.",
      "A20": "ResearcherA achieves a breakthrough.",
      "A21": "ResearcherA receives recognition.",
      "A22": "ResearcherA receives an award.",
      "A23": "ResearcherA collaborates with ResearcherB.",
      "A24": "InstituteM completes a study on SubstanceGamma.",
      "A25": "InstituteN completes a study on SubstanceGamma.",
      "A26": "InstituteM initiates a trial for DiseaseAlpha.",
      "A27": "InstituteN initiates a trial for DiseaseAlpha.",
      "A28": "InstituteM obtains ethics approval.",
      "A29": "InstituteN obtains ethics approval.",
      "A30": "InstituteM faces ethical issues.",
      "A31": "ResearcherC violates protocol.",
      "A32": "ResearcherD violates protocol.",
      "A33": "SubstanceGamma shows efficacy against DiseaseAlpha.",
      "A34": "SubstanceGamma shows toxicity.",
      "A35": "SubstanceGamma passes a safety test.",
      "A36": "CompanyX conducts preclinical studies on SubstanceGamma.",
      "A37": "CompanyY conducts preclinical studies on SubstanceGamma.",
      "A38": "CompanyX halts development of SubstanceGamma.",
      "A39": "CompanyY halts development of SubstanceGamma.",
      "A40": "CompanyX continues research.",
      "A41": "CompanyY continues research.",
      "A42": "CompanyX forms a consortium with CompanyY.",
      "A43": "CompanyY forms a consortium with CompanyX.",
      "A44": "CompanyX dissolves its partnership with CompanyY.",
      "A45": "CompanyY dissolves its partnership with CompanyX.",
      "A46": "CompanyX seeks mediation with CompanyY.",
      "A47": "CompanyX and CompanyY reach a settlement.",
      "A48": "CompanyX renews collaboration with CompanyY.",
      "A49": "CompanyZ withdraws its application from the FDA.",
      "A50": "CompanyW withdraws its application from the FDA.",
      "A51": "CompanyZ faces regulatory hurdles.",
      "A52": "CompanyW faces regulatory hurdles.",
      "A53": "CompanyZ encounters compliance issues.",
      "A54": "CompanyW encounters compliance issues.",
      "A55": "CompanyY challenges CompanyX's patent.",
      "A56": "CompanyZ challenges CompanyX's patent.",
      "A57": "CompanyY loses a lawsuit.",
      "A58": "CompanyX wins a lawsuit.",
      "A59": "CompanyY appeals the decision.",
      "A60": "CompanyZ appeals the decision.",
      "A61": "CompanyY accepts the ruling.",
      "G": "DiseaseAlpha has a successful treatment."
    },
    "prover9_expressions": [
      "(develops_cure(CompanyX, DiseaseAlpha) -> successful_treatment(DiseaseAlpha))",
      "(develops_cure(CompanyX, DiseaseAlpha) | develops_cure(CompanyY, DiseaseAlpha))",
      "(publishes_paper(ResearcherA, JournalScience) -> -experiences_setback(CompanyX, ClinicalTrial))",
      "(publishes_paper(ResearcherB, JournalNature) | publishes_paper(ResearcherA, JournalScience))",
      "(discovers_mechanism(ResearcherA, SubstanceGamma) -> -publishes_paper(ResearcherB, JournalNature))",
      "(develops_resistance(DiseaseAlpha, TreatmentBeta) -> requires_new_treatment(DiseaseAlpha))",
      "(secures_patent(CompanyX, SubstanceGamma) -> successful_treatment(DiseaseAlpha))",
      "(licenses_technology(CompanyY, CompanyX) -> shares_intellectual_property(CompanyX, CompanyY))",
      "(protects_patent(CompanyX) -> -shares_intellectual_property(CompanyX, CompanyY))",
      "(develops_cure(CompanyY, DiseaseAlpha) -> successful_treatment(DiseaseAlpha))",
      "(achieves_breakthrough(ResearcherA) | successful_treatment(DiseaseAlpha))",
      "(receives_award(ResearcherA) -> -receives_recognition(ResearcherA))",
      "(collaborates(ResearcherA, ResearcherB) | (-(achieves_breakthrough(ResearcherA) | successful_treatment(DiseaseAlpha)) -> receives_award(ResearcherA)))",
      "(completes_study(InstituteM, SubstanceGamma) -> successful_treatment(DiseaseAlpha))",
      "(completes_study(InstituteM, SubstanceGamma) | completes_study(InstituteN, SubstanceGamma))",
      "(completes_study(InstituteN, SubstanceGamma) -> successful_treatment(DiseaseAlpha))",
      "(initiates_trial(InstituteM, DiseaseAlpha) -> completes_study(InstituteM, SubstanceGamma))",
      "(initiates_trial(InstituteM, DiseaseAlpha) | initiates_trial(InstituteN, DiseaseAlpha))",
      "(initiates_trial(InstituteN, DiseaseAlpha) -> completes_study(InstituteN, SubstanceGamma))",
      "(obtains_ethics_approval(InstituteM) -> initiates_trial(InstituteM, DiseaseAlpha))",
      "(obtains_ethics_approval(InstituteM) | obtains_ethics_approval(InstituteN))",
      "(obtains_ethics_approval(InstituteN) -> initiates_trial(InstituteN, DiseaseAlpha))",
      "(conducts_research(CompanyX, SubstanceGamma) -> develops_cure(CompanyX, DiseaseAlpha))",
      "(conducts_research(CompanyX, SubstanceGamma) | conducts_research(CompanyY, SubstanceGamma))",
      "(violates_protocol(ResearcherC) -> -faces_ethical_issues(InstituteM))",
      "(violates_protocol(ResearcherC) | violates_protocol(ResearcherD))",
      "(violates_protocol(ResearcherD) -> -faces_ethical_issues(InstituteM))",
      "(shows_efficacy(SubstanceGamma, DiseaseAlpha) -> shows_toxicity(SubstanceGamma))",
      "(shows_efficacy(SubstanceGamma, DiseaseAlpha) | -receives_funding(CompanyX, GrantOne))",
      "(shows_toxicity(SubstanceGamma) -> passes_safety_test(SubstanceGamma))",
      "(shows_toxicity(SubstanceGamma) -> -passes_safety_test(SubstanceGamma))",
      "(conducts_preclinical(CompanyX, SubstanceGamma) -> receives_funding(CompanyY, GrantOne))",
      "(conducts_preclinical(CompanyX, SubstanceGamma) | conducts_preclinical(CompanyY, SubstanceGamma))",
      "(conducts_preclinical(CompanyY, SubstanceGamma) -> -receives_funding(CompanyX, GrantOne))",
      "(halts_development(CompanyY, SubstanceGamma) -> halts_development(CompanyX, SubstanceGamma))",
      "(conducts_research(CompanyY, SubstanceGamma) -> develops_cure(CompanyY, DiseaseAlpha))",
      "(continues_research(CompanyX) | (halts_development(CompanyY, SubstanceGamma) -> halts_development(CompanyX, SubstanceGamma)))",
      "(continues_research(CompanyY) | -continues_research(CompanyX))",
      "(forms_consortium(CompanyY, CompanyX) -> forms_consortium(CompanyX, CompanyY))",
      "(dissolves_partnership(CompanyY, CompanyX) -> -dissolves_partnership(CompanyX, CompanyY))",
      "(withdraws_application(CompanyZ, FDA) -> -receives_approval(CompanyZ, FDA))",
      "(withdraws_application(CompanyZ, FDA) | withdraws_application(CompanyW, FDA))",
      "(receives_funding(CompanyX, GrantOne) | (conducts_research(CompanyX, SubstanceGamma) -> develops_cure(CompanyX, DiseaseAlpha)))",
      "(withdraws_application(CompanyW, FDA) -> -receives_approval(CompanyZ, FDA))",
      "(faces_regulatory_hurdles(CompanyZ) -> withdraws_application(CompanyZ, FDA))",
      "(faces_regulatory_hurdles(CompanyZ) | faces_regulatory_hurdles(CompanyW))",
      "(faces_regulatory_hurdles(CompanyW) -> withdraws_application(CompanyW, FDA))",
      "(faces_regulatory_hurdles(CompanyW) -> encounters_compliance_issues(CompanyZ))",
      "(encounters_compliance_issues(CompanyZ) -> withdraws_application(CompanyW, FDA))",
      "(encounters_compliance_issues(CompanyZ) -> encounters_compliance_issues(CompanyW))",
      "(encounters_compliance_issues(CompanyW) -> withdraws_application(CompanyW, FDA))",
      "(challenges_patent(CompanyY, CompanyX) -> -licenses_technology(CompanyY, CompanyX))",
      "(challenges_patent(CompanyY, CompanyX) | challenges_patent(CompanyZ, CompanyX))",
      "(challenges_patent(CompanyZ, CompanyX) -> -licenses_technology(CompanyY, CompanyX))",
      "(appeals_decision(CompanyY) -> (-(-(challenges_patent(CompanyZ, CompanyX) -> -licenses_technology(CompanyY, CompanyX)) -> -loses_lawsuit(CompanyY)) -> wins_lawsuit(CompanyX)))",
      "(appeals_decision(CompanyY) | appeals_decision(CompanyZ))",
      "(receives_funding(CompanyY, GrantOne) | -receives_funding(CompanyX, GrantOne))",
      "(appeals_decision(CompanyZ) -> (-(-(challenges_patent(CompanyZ, CompanyX) -> -licenses_technology(CompanyY, CompanyX)) -> -loses_lawsuit(CompanyY)) -> wins_lawsuit(CompanyX)))",
      "(applies_for_grant(CompanyZ, GrantOne) -> (receives_funding(CompanyY, GrantOne) | -receives_funding(CompanyX, GrantOne)))",
      "(receives_approval(CompanyZ, FDA) | applies_for_grant(CompanyZ, GrantOne))",
      "(submits_application(CompanyZ, FDA) | -receives_approval(CompanyZ, FDA))",
      "(-(develops_cure(CompanyX, DiseaseAlpha) | develops_cure(CompanyY, DiseaseAlpha)) -> forms_consortium(CompanyX, CompanyY))",
      "(-(develops_cure(CompanyX, DiseaseAlpha) | develops_cure(CompanyY, DiseaseAlpha)) -> forms_consortium(CompanyY, CompanyX))",
      "(-(develops_cure(CompanyX, DiseaseAlpha) | develops_cure(CompanyY, DiseaseAlpha)) -> -forms_consortium(CompanyX, CompanyY))",
      "(-(achieves_breakthrough(ResearcherA) | successful_treatment(DiseaseAlpha)) -> receives_recognition(ResearcherA))",
      "(-(achieves_breakthrough(ResearcherA) | successful_treatment(DiseaseAlpha)) -> receives_award(ResearcherA))",
      "(-(achieves_breakthrough(ResearcherA) | successful_treatment(DiseaseAlpha)) -> -receives_recognition(ResearcherA))",
      "(-(obtains_ethics_approval(InstituteN) -> initiates_trial(InstituteN, DiseaseAlpha)) -> faces_ethical_issues(InstituteM))",
      "(-(conducts_preclinical(CompanyX, SubstanceGamma) | conducts_preclinical(CompanyY, SubstanceGamma)) -> halts_development(CompanyX, SubstanceGamma))",
      "(-(conducts_preclinical(CompanyX, SubstanceGamma) | conducts_preclinical(CompanyY, SubstanceGamma)) -> halts_development(CompanyY, SubstanceGamma))",
      "(-(forms_consortium(CompanyY, CompanyX) -> forms_consortium(CompanyX, CompanyY)) -> dissolves_partnership(CompanyX, CompanyY))",
      "(-(forms_consortium(CompanyY, CompanyX) -> forms_consortium(CompanyX, CompanyY)) -> dissolves_partnership(CompanyY, CompanyX))",
      "(-(forms_consortium(CompanyY, CompanyX) -> forms_consortium(CompanyX, CompanyY)) -> -dissolves_partnership(CompanyX, CompanyY))",
      "(-(dissolves_partnership(CompanyY, CompanyX) -> -dissolves_partnership(CompanyX, CompanyY)) -> seeks_mediation(CompanyX, CompanyY))",
      "(-(dissolves_partnership(CompanyY, CompanyX) -> -dissolves_partnership(CompanyX, CompanyY)) -> -seeks_mediation(CompanyX, CompanyY))",
      "(-(challenges_patent(CompanyZ, CompanyX) -> -licenses_technology(CompanyY, CompanyX)) -> loses_lawsuit(CompanyY))",
      "(-(challenges_patent(CompanyZ, CompanyX) -> -licenses_technology(CompanyY, CompanyX)) -> -loses_lawsuit(CompanyY))",
      "(-(appeals_decision(CompanyY) | appeals_decision(CompanyZ)) -> accepts_ruling(CompanyY))",
      "(-(appeals_decision(CompanyY) | appeals_decision(CompanyZ)) -> -accepts_ruling(CompanyY))",
      "(-(-(dissolves_partnership(CompanyY, CompanyX) -> -dissolves_partnership(CompanyX, CompanyY)) -> seeks_mediation(CompanyX, CompanyY)) -> reaches_settlement(CompanyX, CompanyY))",
      "(-(-(dissolves_partnership(CompanyY, CompanyX) -> -dissolves_partnership(CompanyX, CompanyY)) -> seeks_mediation(CompanyX, CompanyY)) -> -reaches_settlement(CompanyX, CompanyY))",
      "(-(-(challenges_patent(CompanyZ, CompanyX) -> -licenses_technology(CompanyY, CompanyX)) -> -loses_lawsuit(CompanyY)) -> wins_lawsuit(CompanyX))",
      "(-(-(challenges_patent(CompanyZ, CompanyX) -> -licenses_technology(CompanyY, CompanyX)) -> -loses_lawsuit(CompanyY)) -> -wins_lawsuit(CompanyX))",
      "(-(-(-(dissolves_partnership(CompanyY, CompanyX) -> -dissolves_partnership(CompanyX, CompanyY)) -> seeks_mediation(CompanyX, CompanyY)) -> -reaches_settlement(CompanyX, CompanyY)) -> renews_collaboration(CompanyX, CompanyY))",
      "(-discovers_mechanism(ResearcherA, SubstanceGamma) -> develops_resistance(DiseaseAlpha, TreatmentBeta))",
      "(-secures_patent(CompanyX, SubstanceGamma) -> licenses_technology(CompanyY, CompanyX))",
      "(-successful_treatment(DiseaseAlpha) -> experiences_setback(CompanyX, ClinicalTrial))",
      "publishes_paper(ResearcherA, JournalScience)",
      "discovers_mechanism(ResearcherA, SubstanceGamma)",
      "secures_patent(CompanyX, SubstanceGamma)",
      "protects_patent(CompanyX)",
      "applies_for_grant(CompanyZ, GrantOne)",
      "successful_treatment(DiseaseAlpha)",
      "-experiences_setback(CompanyX, ClinicalTrial)",
      "-publishes_paper(ResearcherB, JournalNature)",
      "-develops_resistance(DiseaseAlpha, TreatmentBeta)",
      "-requires_new_treatment(DiseaseAlpha)",
      "-licenses_technology(CompanyY, CompanyX)",
      "-shares_intellectual_property(CompanyX, CompanyY)",
      "-achieves_breakthrough(ResearcherA)",
      "-collaborates(ResearcherA, ResearcherB)",
      "-faces_ethical_issues(InstituteM)",
      "-shows_efficacy(SubstanceGamma, DiseaseAlpha)",
      "-shows_toxicity(SubstanceGamma)",
      "-halts_development(CompanyX, SubstanceGamma)",
      "-continues_research(CompanyX)",
      "-continues_research(CompanyY)",
      "-renews_collaboration(CompanyX, CompanyY)",
      "-receives_funding(CompanyX, GrantOne)",
      "-receives_funding(CompanyY, GrantOne)",
      "-receives_approval(CompanyZ, FDA)",
      "-submits_application(CompanyZ, FDA)"
    ],
    "natural_expressions": [
      "If CompanyX develops a cure for DiseaseAlpha, then DiseaseAlpha has a successful treatment.",
      "Either CompanyX develops a cure for DiseaseAlpha or CompanyY develops a cure for DiseaseAlpha.",
      "Provided that ResearcherA publishes a paper in JournalScience, it is not the case that CompanyX experiences a setback in a clinical trial.",
      "ResearcherB publishes a paper in JournalNature or ResearcherA publishes a paper in JournalScience.",
      "Whenever ResearcherA discovers the mechanism of SubstanceGamma, ResearcherB does not publish a paper in JournalNature.",
      "If DiseaseAlpha develops resistance to TreatmentBeta, it requires a new treatment.",
      "Under the condition that CompanyX secures a patent for SubstanceGamma, DiseaseAlpha has a successful treatment.",
      "If CompanyY licenses technology from CompanyX, then CompanyX shares intellectual property with CompanyY.",
      "Provided that CompanyX protects its patent, it is not the case that CompanyX shares intellectual property with CompanyY.",
      "If CompanyY develops a cure for DiseaseAlpha, then DiseaseAlpha has a successful treatment.",
      "Either ResearcherA achieves a breakthrough or DiseaseAlpha has a successful treatment.",
      "Whenever ResearcherA receives an award, ResearcherA does not receive recognition.",
      "ResearcherA collaborates with ResearcherB or, if neither ResearcherA achieves a breakthrough nor DiseaseAlpha has a successful treatment, ResearcherA receives an award.",
      "If InstituteM completes a study on SubstanceGamma, then DiseaseAlpha has a successful treatment.",
      "InstituteM completes a study on SubstanceGamma or InstituteN completes a study on SubstanceGamma.",
      "Under the condition that InstituteN completes a study on SubstanceGamma, DiseaseAlpha has a successful treatment.",
      "If InstituteM initiates a trial for DiseaseAlpha, then InstituteM completes a study on SubstanceGamma.",
      "InstituteM initiates a trial for DiseaseAlpha or InstituteN initiates a trial for DiseaseAlpha.",
      "Provided that InstituteN initiates a trial for DiseaseAlpha, InstituteN completes a study on SubstanceGamma.",
      "If InstituteM obtains ethics approval, then InstituteM initiates a trial for DiseaseAlpha.",
      "InstituteM obtains ethics approval or InstituteN obtains ethics approval.",
      "Under the condition that InstituteN obtains ethics approval, InstituteN initiates a trial for DiseaseAlpha.",
      "If CompanyX conducts research on SubstanceGamma, then CompanyX develops a cure for DiseaseAlpha.",
      "Either CompanyX conducts research on SubstanceGamma or CompanyY conducts research on SubstanceGamma.",
      "Whenever ResearcherC violates protocol, InstituteM does not face ethical issues.",
      "ResearcherC violates protocol or ResearcherD violates protocol.",
      "If ResearcherD violates protocol, then InstituteM does not face ethical issues.",
      "Provided that SubstanceGamma shows efficacy against DiseaseAlpha, it shows toxicity.",
      "SubstanceGamma shows efficacy against DiseaseAlpha or CompanyX does not receive funding from GrantOne.",
      "If SubstanceGamma shows toxicity, then it passes a safety test.",
      "Under the condition that SubstanceGamma shows toxicity, it does not pass a safety test.",
      "If CompanyX conducts preclinical studies on SubstanceGamma, then CompanyY receives funding from GrantOne.",
      "CompanyX conducts preclinical studies on SubstanceGamma or CompanyY conducts preclinical studies on SubstanceGamma.",
      "Provided that CompanyY conducts preclinical studies on SubstanceGamma, CompanyX does not receive funding from GrantOne.",
      "If CompanyY halts development of SubstanceGamma, then CompanyX halts development of SubstanceGamma.",
      "If CompanyY conducts research on SubstanceGamma, then CompanyY develops a cure for DiseaseAlpha.",
      "CompanyX continues research or, if CompanyY halts development of SubstanceGamma, then CompanyX halts development of SubstanceGamma.",
      "CompanyY continues research or CompanyX does not continue research.",
      "If CompanyY forms a consortium with CompanyX, then CompanyX forms a consortium with CompanyY.",
      "Under the condition that CompanyY dissolves its partnership with CompanyX, CompanyX does not dissolve its partnership with CompanyY.",
      "If CompanyZ withdraws its application from the FDA, then CompanyZ does not receive approval from the FDA.",
      "CompanyZ withdraws its application from the FDA or CompanyW withdraws its application from the FDA.",
      "CompanyX receives funding from GrantOne or, if CompanyX conducts research on SubstanceGamma, then CompanyX develops a cure for DiseaseAlpha.",
      "Provided that CompanyW withdraws its application from the FDA, CompanyZ does not receive approval from the FDA.",
      "If CompanyZ faces regulatory hurdles, then CompanyZ withdraws its application from the FDA.",
      "CompanyZ faces regulatory hurdles or CompanyW faces regulatory hurdles.",
      "Under the condition that CompanyW faces regulatory hurdles, CompanyW withdraws its application from the FDA.",
      "If CompanyW faces regulatory hurdles, then CompanyZ encounters compliance issues.",
      "If CompanyZ encounters compliance issues, then CompanyW withdraws its application from the FDA.",
      "Whenever CompanyZ encounters compliance issues, CompanyW encounters compliance issues.",
      "Provided that CompanyW encounters compliance issues, CompanyW withdraws its application from the FDA.",
      "If CompanyY challenges CompanyX's patent, then CompanyY does not license technology from CompanyX.",
      "CompanyY challenges CompanyX's patent or CompanyZ challenges CompanyX's patent.",
      "Under the condition that CompanyZ challenges CompanyX's patent, CompanyY does not license technology from CompanyX.",
      "If CompanyY appeals the decision, then, if it is not the case that CompanyZ challenging CompanyX's patent implies that CompanyY does not license technology from CompanyX, then CompanyX wins a lawsuit.",
      "CompanyY appeals the decision or CompanyZ appeals the decision.",
      "CompanyY receives funding from GrantOne or CompanyX does not receive funding from GrantOne.",
      "If CompanyZ appeals the decision, then, provided that it is not the case that CompanyZ challenging CompanyX's patent implies that CompanyY does not license technology from CompanyX, then CompanyX wins a lawsuit.",
      "Under the condition that CompanyZ applies for GrantOne, CompanyY receives funding from GrantOne or CompanyX does not receive funding from GrantOne.",
      "CompanyZ receives approval from the FDA or CompanyZ applies for GrantOne.",
      "CompanyZ submits an application to the FDA or CompanyZ does not receive approval from the FDA.",
      "If it is not the case that either CompanyX develops a cure for DiseaseAlpha or CompanyY develops a cure for DiseaseAlpha, then CompanyX forms a consortium with CompanyY.",
      "Provided that it is not the case that either CompanyX develops a cure for DiseaseAlpha or CompanyY develops a cure for DiseaseAlpha, CompanyY forms a consortium with CompanyX.",
      "If it is not the case that either CompanyX develops a cure for DiseaseAlpha or CompanyY develops a cure for DiseaseAlpha, then CompanyX does not form a consortium with CompanyY.",
      "Under the condition that it is not the case that either ResearcherA achieves a breakthrough or DiseaseAlpha has a successful treatment, ResearcherA receives recognition.",
      "If it is not the case that either ResearcherA achieves a breakthrough or DiseaseAlpha has a successful treatment, then ResearcherA receives an award.",
      "Provided that it is not the case that either ResearcherA achieves a breakthrough or DiseaseAlpha has a successful treatment, ResearcherA does not receive recognition.",
      "If it is not the case that InstituteN obtaining ethics approval implies that InstituteN initiates a trial for DiseaseAlpha, then InstituteM faces ethical issues.",
      "Under the condition that it is not the case that either CompanyX conducts preclinical studies on SubstanceGamma or CompanyY conducts preclinical studies on SubstanceGamma, CompanyX halts development of SubstanceGamma.",
      "If it is not the case that either CompanyX conducts preclinical studies on SubstanceGamma or CompanyY conducts preclinical studies on SubstanceGamma, then CompanyY halts development of SubstanceGamma.",
      "Provided that it is not the case that CompanyY forming a consortium with CompanyX implies that CompanyX forms a consortium with CompanyY, CompanyX dissolves its partnership with CompanyY.",
      "If it is not the case that CompanyY forming a consortium with CompanyX implies that CompanyX forms a consortium with CompanyY, then CompanyY dissolves its partnership with CompanyX.",
      "Under the condition that it is not the case that CompanyY forming a consortium with CompanyX implies that CompanyX forms a consortium with CompanyY, CompanyX does not dissolve its partnership with CompanyY.",
      "If it is not the case that CompanyY dissolving its partnership with CompanyX implies that CompanyX does not dissolve its partnership with CompanyY, then CompanyX seeks mediation with CompanyY.",
      "Provided that it is not the case that CompanyY dissolving its partnership with CompanyX implies that CompanyX does not dissolve its partnership with CompanyY, CompanyX does not seek mediation with CompanyY.",
      "Under the condition that it is not the case that CompanyZ challenging CompanyX's patent implies that CompanyY does not license technology from CompanyX, CompanyY loses a lawsuit.",
      "If it is not the case that CompanyZ challenging CompanyX's patent implies that CompanyY does not license technology from CompanyX, then CompanyY does not lose a lawsuit.",
      "Provided that it is not the case that either CompanyY appeals the decision or CompanyZ appeals the decision, CompanyY accepts the ruling.",
      "If it is not the case that either CompanyY appeals the decision or CompanyZ appeals the decision, then CompanyY does not accept the ruling.",
      "Under the condition that it is not the case that CompanyY dissolving its partnership with CompanyX not implying that CompanyX does not dissolve its partnership with CompanyY implies that CompanyX seeks mediation with CompanyY, CompanyX and CompanyY reach a settlement.",
      "If it is not the case that CompanyY dissolving its partnership with CompanyX not implying that CompanyX does not dissolve its partnership with CompanyY implies that CompanyX seeks mediation with CompanyY, then CompanyX and CompanyY do not reach a settlement.",
      "Provided that it is not the case that CompanyZ challenging CompanyX's patent not implying that CompanyY does not license technology from CompanyX implies that CompanyY does not lose a lawsuit, CompanyX wins a lawsuit.",
      "Under the condition that it is not the case that CompanyZ challenging CompanyX's patent not implying that CompanyY does not license technology from CompanyX implies that CompanyY does not lose a lawsuit, CompanyX does not win a lawsuit.",
      "If it is not the case that CompanyY dissolving its partnership with CompanyX not implying that CompanyX does not dissolve its partnership with CompanyY not implying that CompanyX seeks mediation with CompanyY implies that CompanyX and CompanyY do not reach a settlement, then CompanyX renews collaboration with CompanyY.",
      "If ResearcherA does not discover the mechanism of SubstanceGamma, then DiseaseAlpha develops resistance to TreatmentBeta.",
      "Under the condition that CompanyX does not secure a patent for SubstanceGamma, CompanyY licenses technology from CompanyX.",
      "Provided that DiseaseAlpha does not have a successful treatment, CompanyX experiences a setback in a clinical trial.",
      "ResearcherA publishes a paper in JournalScience.",
      "ResearcherA discovers the mechanism of SubstanceGamma.",
      "CompanyX secures a patent for SubstanceGamma.",
      "CompanyX protects its patent.",
      "CompanyZ applies for GrantOne.",
      "DiseaseAlpha has a successful treatment.",
      "CompanyX does not experience a setback in a clinical trial.",
      "ResearcherB does not publish a paper in JournalNature.",
      "DiseaseAlpha does not develop resistance to TreatmentBeta.",
      "DiseaseAlpha does not require a new treatment.",
      "CompanyY does not license technology from CompanyX.",
      "CompanyX does not share intellectual property with CompanyY.",
      "ResearcherA does not achieve a breakthrough.",
      "ResearcherA does not collaborate with ResearcherB.",
      "InstituteM does not face ethical issues.",
      "SubstanceGamma does not show efficacy against DiseaseAlpha.",
      "SubstanceGamma does not show toxicity.",
      "CompanyX does not halt development of SubstanceGamma.",
      "CompanyX does not continue research.",
      "CompanyY does not continue research.",
      "CompanyX does not renew collaboration with CompanyY.",
      "CompanyX does not receive funding from GrantOne.",
      "CompanyY does not receive funding from GrantOne.",
      "CompanyZ does not receive approval from the FDA.",
      "CompanyZ does not submit an application to the FDA."
    ],
    "node_mappings": {
      "(A1 → G)": {
        "formal": "(A1 → G)",
        "prover9": "(A1 -> G)",
        "prover9_expression": "(develops_cure(CompanyX, DiseaseAlpha) -> successful_treatment(DiseaseAlpha))",
        "natural": "If CompanyX develops a cure for DiseaseAlpha, then DiseaseAlpha has a successful treatment."
      },
      "(A1 ∨ A2)": {
        "formal": "(A1 ∨ A2)",
        "prover9": "(A1 | A2)",
        "prover9_expression": "(develops_cure(CompanyX, DiseaseAlpha) | develops_cure(CompanyY, DiseaseAlpha))",
        "natural": "Either CompanyX develops a cure for DiseaseAlpha or CompanyY develops a cure for DiseaseAlpha."
      },
      "(A11 → ¬A10)": {
        "formal": "(A11 → ¬A10)",
        "prover9": "(A11 -> -A10)",
        "prover9_expression": "(publishes_paper(ResearcherA, JournalScience) -> -experiences_setback(CompanyX, ClinicalTrial))",
        "natural": "Provided that ResearcherA publishes a paper in JournalScience, it is not the case that CompanyX experiences a setback in a clinical trial."
      },
      "(A12 ∨ A11)": {
        "formal": "(A12 ∨ A11)",
        "prover9": "(A12 | A11)",
        "prover9_expression": "(publishes_paper(ResearcherB, JournalNature) | publishes_paper(ResearcherA, JournalScience))",
        "natural": "ResearcherB publishes a paper in JournalNature or ResearcherA publishes a paper in JournalScience."
      },
      "(A13 → ¬A12)": {
        "formal": "(A13 → ¬A12)",
        "prover9": "(A13 -> -A12)",
        "prover9_expression": "(discovers_mechanism(ResearcherA, SubstanceGamma) -> -publishes_paper(ResearcherB, JournalNature))",
        "natural": "Whenever ResearcherA discovers the mechanism of SubstanceGamma, ResearcherB does not publish a paper in JournalNature."
      },
      "(A14 → A15)": {
        "formal": "(A14 → A15)",
        "prover9": "(A14 -> A15)",
        "prover9_expression": "(develops_resistance(DiseaseAlpha, TreatmentBeta) -> requires_new_treatment(DiseaseAlpha))",
        "natural": "If DiseaseAlpha develops resistance to TreatmentBeta, it requires a new treatment."
      },
      "(A16 → G)": {
        "formal": "(A16 → G)",
        "prover9": "(A16 -> G)",
        "prover9_expression": "(secures_patent(CompanyX, SubstanceGamma) -> successful_treatment(DiseaseAlpha))",
        "natural": "Under the condition that CompanyX secures a patent for SubstanceGamma, DiseaseAlpha has a successful treatment."
      },
      "(A17 → A18)": {
        "formal": "(A17 → A18)",
        "prover9": "(A17 -> A18)",
        "prover9_expression": "(licenses_technology(CompanyY, CompanyX) -> shares_intellectual_property(CompanyX, CompanyY))",
        "natural": "If CompanyY licenses technology from CompanyX, then CompanyX shares intellectual property with CompanyY."
      },
      "(A19 → ¬A18)": {
        "formal": "(A19 → ¬A18)",
        "prover9": "(A19 -> -A18)",
        "prover9_expression": "(protects_patent(CompanyX) -> -shares_intellectual_property(CompanyX, CompanyY))",
        "natural": "Provided that CompanyX protects its patent, it is not the case that CompanyX shares intellectual property with CompanyY."
      },
      "(A2 → G)": {
        "formal": "(A2 → G)",
        "prover9": "(A2 -> G)",
        "prover9_expression": "(develops_cure(CompanyY, DiseaseAlpha) -> successful_treatment(DiseaseAlpha))",
        "natural": "If CompanyY develops a cure for DiseaseAlpha, then DiseaseAlpha has a successful treatment."
      },
      "(A20 ∨ G)": {
        "formal": "(A20 ∨ G)",
        "prover9": "(A20 | G)",
        "prover9_expression": "(achieves_breakthrough(ResearcherA) | successful_treatment(DiseaseAlpha))",
        "natural": "Either ResearcherA achieves a breakthrough or DiseaseAlpha has a successful treatment."
      },
      "(A22 → ¬A21)": {
        "formal": "(A22 → ¬A21)",
        "prover9": "(A22 -> -A21)",
        "prover9_expression": "(receives_award(ResearcherA) -> -receives_recognition(ResearcherA))",
        "natural": "Whenever ResearcherA receives an award, ResearcherA does not receive recognition."
      },
      "(A23 ∨ (¬(A20 ∨ G) → A22))": {
        "formal": "(A23 ∨ (¬(A20 ∨ G) → A22))",
        "prover9": "(A23 | (-(A20 | G) -> A22))",
        "prover9_expression": "(collaborates(ResearcherA, ResearcherB) | (-(achieves_breakthrough(ResearcherA) | successful_treatment(DiseaseAlpha)) -> receives_award(ResearcherA)))",
        "natural": "ResearcherA collaborates with ResearcherB or, if neither ResearcherA achieves a breakthrough nor DiseaseAlpha has a successful treatment, ResearcherA receives an award."
      },
      "(A24 → G)": {
        "formal": "(A24 → G)",
        "prover9": "(A24 -> G)",
        "prover9_expression": "(completes_study(InstituteM, SubstanceGamma) -> successful_treatment(DiseaseAlpha))",
        "natural": "If InstituteM completes a study on SubstanceGamma, then DiseaseAlpha has a successful treatment."
      },
      "(A24 ∨ A25)": {
        "formal": "(A24 ∨ A25)",
        "prover9": "(A24 | A25)",
        "prover9_expression": "(completes_study(InstituteM, SubstanceGamma) | completes_study(InstituteN, SubstanceGamma))",
        "natural": "InstituteM completes a study on SubstanceGamma or InstituteN completes a study on SubstanceGamma."
      },
      "(A25 → G)": {
        "formal": "(A25 → G)",
        "prover9": "(A25 -> G)",
        "prover9_expression": "(completes_study(InstituteN, SubstanceGamma) -> successful_treatment(DiseaseAlpha))",
        "natural": "Under the condition that InstituteN completes a study on SubstanceGamma, DiseaseAlpha has a successful treatment."
      },
      "(A26 → A24)": {
        "formal": "(A26 → A24)",
        "prover9": "(A26 -> A24)",
        "prover9_expression": "(initiates_trial(InstituteM, DiseaseAlpha) -> completes_study(InstituteM, SubstanceGamma))",
        "natural": "If InstituteM initiates a trial for DiseaseAlpha, then InstituteM completes a study on SubstanceGamma."
      },
      "(A26 ∨ A27)": {
        "formal": "(A26 ∨ A27)",
        "prover9": "(A26 | A27)",
        "prover9_expression": "(initiates_trial(InstituteM, DiseaseAlpha) | initiates_trial(InstituteN, DiseaseAlpha))",
        "natural": "InstituteM initiates a trial for DiseaseAlpha or InstituteN initiates a trial for DiseaseAlpha."
      },
      "(A27 → A25)": {
        "formal": "(A27 → A25)",
        "prover9": "(A27 -> A25)",
        "prover9_expression": "(initiates_trial(InstituteN, DiseaseAlpha) -> completes_study(InstituteN, SubstanceGamma))",
        "natural": "Provided that InstituteN initiates a trial for DiseaseAlpha, InstituteN completes a study on SubstanceGamma."
      },
      "(A28 → A26)": {
        "formal": "(A28 → A26)",
        "prover9": "(A28 -> A26)",
        "prover9_expression": "(obtains_ethics_approval(InstituteM) -> initiates_trial(InstituteM, DiseaseAlpha))",
        "natural": "If InstituteM obtains ethics approval, then InstituteM initiates a trial for DiseaseAlpha."
      },
      "(A28 ∨ A29)": {
        "formal": "(A28 ∨ A29)",
        "prover9": "(A28 | A29)",
        "prover9_expression": "(obtains_ethics_approval(InstituteM) | obtains_ethics_approval(InstituteN))",
        "natural": "InstituteM obtains ethics approval or InstituteN obtains ethics approval."
      },
      "(A29 → A27)": {
        "formal": "(A29 → A27)",
        "prover9": "(A29 -> A27)",
        "prover9_expression": "(obtains_ethics_approval(InstituteN) -> initiates_trial(InstituteN, DiseaseAlpha))",
        "natural": "Under the condition that InstituteN obtains ethics approval, InstituteN initiates a trial for DiseaseAlpha."
      },
      "(A3 → A1)": {
        "formal": "(A3 → A1)",
        "prover9": "(A3 -> A1)",
        "prover9_expression": "(conducts_research(CompanyX, SubstanceGamma) -> develops_cure(CompanyX, DiseaseAlpha))",
        "natural": "If CompanyX conducts research on SubstanceGamma, then CompanyX develops a cure for DiseaseAlpha."
      },
      "(A3 ∨ A4)": {
        "formal": "(A3 ∨ A4)",
        "prover9": "(A3 | A4)",
        "prover9_expression": "(conducts_research(CompanyX, SubstanceGamma) | conducts_research(CompanyY, SubstanceGamma))",
        "natural": "Either CompanyX conducts research on SubstanceGamma or CompanyY conducts research on SubstanceGamma."
      },
      "(A31 → ¬A30)": {
        "formal": "(A31 → ¬A30)",
        "prover9": "(A31 -> -A30)",
        "prover9_expression": "(violates_protocol(ResearcherC) -> -faces_ethical_issues(InstituteM))",
        "natural": "Whenever ResearcherC violates protocol, InstituteM does not face ethical issues."
      },
      "(A31 ∨ A32)": {
        "formal": "(A31 ∨ A32)",
        "prover9": "(A31 | A32)",
        "prover9_expression": "(violates_protocol(ResearcherC) | violates_protocol(ResearcherD))",
        "natural": "ResearcherC violates protocol or ResearcherD violates protocol."
      },
      "(A32 → ¬A30)": {
        "formal": "(A32 → ¬A30)",
        "prover9": "(A32 -> -A30)",
        "prover9_expression": "(violates_protocol(ResearcherD) -> -faces_ethical_issues(InstituteM))",
        "natural": "If ResearcherD violates protocol, then InstituteM does not face ethical issues."
      },
      "(A33 → A34)": {
        "formal": "(A33 → A34)",
        "prover9": "(A33 -> A34)",
        "prover9_expression": "(shows_efficacy(SubstanceGamma, DiseaseAlpha) -> shows_toxicity(SubstanceGamma))",
        "natural": "Provided that SubstanceGamma shows efficacy against DiseaseAlpha, it shows toxicity."
      },
      "(A33 ∨ ¬A5)": {
        "formal": "(A33 ∨ ¬A5)",
        "prover9": "(A33 | -A5)",
        "prover9_expression": "(shows_efficacy(SubstanceGamma, DiseaseAlpha) | -receives_funding(CompanyX, GrantOne))",
        "natural": "SubstanceGamma shows efficacy against DiseaseAlpha or CompanyX does not receive funding from GrantOne."
      },
      "(A34 → A35)": {
        "formal": "(A34 → A35)",
        "prover9": "(A34 -> A35)",
        "prover9_expression": "(shows_toxicity(SubstanceGamma) -> passes_safety_test(SubstanceGamma))",
        "natural": "If SubstanceGamma shows toxicity, then it passes a safety test."
      },
      "(A34 → ¬A35)": {
        "formal": "(A34 → ¬A35)",
        "prover9": "(A34 -> -A35)",
        "prover9_expression": "(shows_toxicity(SubstanceGamma) -> -passes_safety_test(SubstanceGamma))",
        "natural": "Under the condition that SubstanceGamma shows toxicity, it does not pass a safety test."
      },
      "(A36 → A6)": {
        "formal": "(A36 → A6)",
        "prover9": "(A36 -> A6)",
        "prover9_expression": "(conducts_preclinical(CompanyX, SubstanceGamma) -> receives_funding(CompanyY, GrantOne))",
        "natural": "If CompanyX conducts preclinical studies on SubstanceGamma, then CompanyY receives funding from GrantOne."
      },
      "(A36 ∨ A37)": {
        "formal": "(A36 ∨ A37)",
        "prover9": "(A36 | A37)",
        "prover9_expression": "(conducts_preclinical(CompanyX, SubstanceGamma) | conducts_preclinical(CompanyY, SubstanceGamma))",
        "natural": "CompanyX conducts preclinical studies on SubstanceGamma or CompanyY conducts preclinical studies on SubstanceGamma."
      },
      "(A37 → ¬A5)": {
        "formal": "(A37 → ¬A5)",
        "prover9": "(A37 -> -A5)",
        "prover9_expression": "(conducts_preclinical(CompanyY, SubstanceGamma) -> -receives_funding(CompanyX, GrantOne))",
        "natural": "Provided that CompanyY conducts preclinical studies on SubstanceGamma, CompanyX does not receive funding from GrantOne."
      },
      "(A39 → A38)": {
        "formal": "(A39 → A38)",
        "prover9": "(A39 -> A38)",
        "prover9_expression": "(halts_development(CompanyY, SubstanceGamma) -> halts_development(CompanyX, SubstanceGamma))",
        "natural": "If CompanyY halts development of SubstanceGamma, then CompanyX halts development of SubstanceGamma."
      },
      "(A4 → A2)": {
        "formal": "(A4 → A2)",
        "prover9": "(A4 -> A2)",
        "prover9_expression": "(conducts_research(CompanyY, SubstanceGamma) -> develops_cure(CompanyY, DiseaseAlpha))",
        "natural": "If CompanyY conducts research on SubstanceGamma, then CompanyY develops a cure for DiseaseAlpha."
      },
      "(A40 ∨ (A39 → A38))": {
        "formal": "(A40 ∨ (A39 → A38))",
        "prover9": "(A40 | (A39 -> A38))",
        "prover9_expression": "(continues_research(CompanyX) | (halts_development(CompanyY, SubstanceGamma) -> halts_development(CompanyX, SubstanceGamma)))",
        "natural": "CompanyX continues research or, if CompanyY halts development of SubstanceGamma, then CompanyX halts development of SubstanceGamma."
      },
      "(A41 ∨ ¬A40)": {
        "formal": "(A41 ∨ ¬A40)",
        "prover9": "(A41 | -A40)",
        "prover9_expression": "(continues_research(CompanyY) | -continues_research(CompanyX))",
        "natural": "CompanyY continues research or CompanyX does not continue research."
      },
      "(A43 → A42)": {
        "formal": "(A43 → A42)",
        "prover9": "(A43 -> A42)",
        "prover9_expression": "(forms_consortium(CompanyY, CompanyX) -> forms_consortium(CompanyX, CompanyY))",
        "natural": "If CompanyY forms a consortium with CompanyX, then CompanyX forms a consortium with CompanyY."
      },
      "(A45 → ¬A44)": {
        "formal": "(A45 → ¬A44)",
        "prover9": "(A45 -> -A44)",
        "prover9_expression": "(dissolves_partnership(CompanyY, CompanyX) -> -dissolves_partnership(CompanyX, CompanyY))",
        "natural": "Under the condition that CompanyY dissolves its partnership with CompanyX, CompanyX does not dissolve its partnership with CompanyY."
      },
      "(A49 → ¬A8)": {
        "formal": "(A49 → ¬A8)",
        "prover9": "(A49 -> -A8)",
        "prover9_expression": "(withdraws_application(CompanyZ, FDA) -> -receives_approval(CompanyZ, FDA))",
        "natural": "If CompanyZ withdraws its application from the FDA, then CompanyZ does not receive approval from the FDA."
      },
      "(A49 ∨ A50)": {
        "formal": "(A49 ∨ A50)",
        "prover9": "(A49 | A50)",
        "prover9_expression": "(withdraws_application(CompanyZ, FDA) | withdraws_application(CompanyW, FDA))",
        "natural": "CompanyZ withdraws its application from the FDA or CompanyW withdraws its application from the FDA."
      },
      "(A5 ∨ (A3 → A1))": {
        "formal": "(A5 ∨ (A3 → A1))",
        "prover9": "(A5 | (A3 -> A1))",
        "prover9_expression": "(receives_funding(CompanyX, GrantOne) | (conducts_research(CompanyX, SubstanceGamma) -> develops_cure(CompanyX, DiseaseAlpha)))",
        "natural": "CompanyX receives funding from GrantOne or, if CompanyX conducts research on SubstanceGamma, then CompanyX develops a cure for DiseaseAlpha."
      },
      "(A50 → ¬A8)": {
        "formal": "(A50 → ¬A8)",
        "prover9": "(A50 -> -A8)",
        "prover9_expression": "(withdraws_application(CompanyW, FDA) -> -receives_approval(CompanyZ, FDA))",
        "natural": "Provided that CompanyW withdraws its application from the FDA, CompanyZ does not receive approval from the FDA."
      },
      "(A51 → A49)": {
        "formal": "(A51 → A49)",
        "prover9": "(A51 -> A49)",
        "prover9_expression": "(faces_regulatory_hurdles(CompanyZ) -> withdraws_application(CompanyZ, FDA))",
        "natural": "If CompanyZ faces regulatory hurdles, then CompanyZ withdraws its application from the FDA."
      },
      "(A51 ∨ A52)": {
        "formal": "(A51 ∨ A52)",
        "prover9": "(A51 | A52)",
        "prover9_expression": "(faces_regulatory_hurdles(CompanyZ) | faces_regulatory_hurdles(CompanyW))",
        "natural": "CompanyZ faces regulatory hurdles or CompanyW faces regulatory hurdles."
      },
      "(A52 → A50)": {
        "formal": "(A52 → A50)",
        "prover9": "(A52 -> A50)",
        "prover9_expression": "(faces_regulatory_hurdles(CompanyW) -> withdraws_application(CompanyW, FDA))",
        "natural": "Under the condition that CompanyW faces regulatory hurdles, CompanyW withdraws its application from the FDA."
      },
      "(A52 → A53)": {
        "formal": "(A52 → A53)",
        "prover9": "(A52 -> A53)",
        "prover9_expression": "(faces_regulatory_hurdles(CompanyW) -> encounters_compliance_issues(CompanyZ))",
        "natural": "If CompanyW faces regulatory hurdles, then CompanyZ encounters compliance issues."
      },
      "(A53 → A50)": {
        "formal": "(A53 → A50)",
        "prover9": "(A53 -> A50)",
        "prover9_expression": "(encounters_compliance_issues(CompanyZ) -> withdraws_application(CompanyW, FDA))",
        "natural": "If CompanyZ encounters compliance issues, then CompanyW withdraws its application from the FDA."
      },
      "(A53 → A54)": {
        "formal": "(A53 → A54)",
        "prover9": "(A53 -> A54)",
        "prover9_expression": "(encounters_compliance_issues(CompanyZ) -> encounters_compliance_issues(CompanyW))",
        "natural": "Whenever CompanyZ encounters compliance issues, CompanyW encounters compliance issues."
      },
      "(A54 → A50)": {
        "formal": "(A54 → A50)",
        "prover9": "(A54 -> A50)",
        "prover9_expression": "(encounters_compliance_issues(CompanyW) -> withdraws_application(CompanyW, FDA))",
        "natural": "Provided that CompanyW encounters compliance issues, CompanyW withdraws its application from the FDA."
      },
      "(A55 → ¬A17)": {
        "formal": "(A55 → ¬A17)",
        "prover9": "(A55 -> -A17)",
        "prover9_expression": "(challenges_patent(CompanyY, CompanyX) -> -licenses_technology(CompanyY, CompanyX))",
        "natural": "If CompanyY challenges CompanyX's patent, then CompanyY does not license technology from CompanyX."
      },
      "(A55 ∨ A56)": {
        "formal": "(A55 ∨ A56)",
        "prover9": "(A55 | A56)",
        "prover9_expression": "(challenges_patent(CompanyY, CompanyX) | challenges_patent(CompanyZ, CompanyX))",
        "natural": "CompanyY challenges CompanyX's patent or CompanyZ challenges CompanyX's patent."
      },
      "(A56 → ¬A17)": {
        "formal": "(A56 → ¬A17)",
        "prover9": "(A56 -> -A17)",
        "prover9_expression": "(challenges_patent(CompanyZ, CompanyX) -> -licenses_technology(CompanyY, CompanyX))",
        "natural": "Under the condition that CompanyZ challenges CompanyX's patent, CompanyY does not license technology from CompanyX."
      },
      "(A59 → (¬(¬(A56 → ¬A17) → ¬A57) → A58))": {
        "formal": "(A59 → (¬(¬(A56 → ¬A17) → ¬A57) → A58))",
        "prover9": "(A59 -> (-(-(A56 -> -A17) -> -A57) -> A58))",
        "prover9_expression": "(appeals_decision(CompanyY) -> (-(-(challenges_patent(CompanyZ, CompanyX) -> -licenses_technology(CompanyY, CompanyX)) -> -loses_lawsuit(CompanyY)) -> wins_lawsuit(CompanyX)))",
        "natural": "If CompanyY appeals the decision, then, if it is not the case that CompanyZ challenging CompanyX's patent implies that CompanyY does not license technology from CompanyX, then CompanyX wins a lawsuit."
      },
      "(A59 ∨ A60)": {
        "formal": "(A59 ∨ A60)",
        "prover9": "(A59 | A60)",
        "prover9_expression": "(appeals_decision(CompanyY) | appeals_decision(CompanyZ))",
        "natural": "CompanyY appeals the decision or CompanyZ appeals the decision."
      },
      "(A6 ∨ ¬A5)": {
        "formal": "(A6 ∨ ¬A5)",
        "prover9": "(A6 | -A5)",
        "prover9_expression": "(receives_funding(CompanyY, GrantOne) | -receives_funding(CompanyX, GrantOne))",
        "natural": "CompanyY receives funding from GrantOne or CompanyX does not receive funding from GrantOne."
      },
      "(A60 → (¬(¬(A56 → ¬A17) → ¬A57) → A58))": {
        "formal": "(A60 → (¬(¬(A56 → ¬A17) → ¬A57) → A58))",
        "prover9": "(A60 -> (-(-(A56 -> -A17) -> -A57) -> A58))",
        "prover9_expression": "(appeals_decision(CompanyZ) -> (-(-(challenges_patent(CompanyZ, CompanyX) -> -licenses_technology(CompanyY, CompanyX)) -> -loses_lawsuit(CompanyY)) -> wins_lawsuit(CompanyX)))",
        "natural": "If CompanyZ appeals the decision, then, provided that it is not the case that CompanyZ challenging CompanyX's patent implies that CompanyY does not license technology from CompanyX, then CompanyX wins a lawsuit."
      },
      "(A7 → (A6 ∨ ¬A5))": {
        "formal": "(A7 → (A6 ∨ ¬A5))",
        "prover9": "(A7 -> (A6 | -A5))",
        "prover9_expression": "(applies_for_grant(CompanyZ, GrantOne) -> (receives_funding(CompanyY, GrantOne) | -receives_funding(CompanyX, GrantOne)))",
        "natural": "Under the condition that CompanyZ applies for GrantOne, CompanyY receives funding from GrantOne or CompanyX does not receive funding from GrantOne."
      },
      "(A8 ∨ A7)": {
        "formal": "(A8 ∨ A7)",
        "prover9": "(A8 | A7)",
        "prover9_expression": "(receives_approval(CompanyZ, FDA) | applies_for_grant(CompanyZ, GrantOne))",
        "natural": "CompanyZ receives approval from the FDA or CompanyZ applies for GrantOne."
      },
      "(A9 ∨ ¬A8)": {
        "formal": "(A9 ∨ ¬A8)",
        "prover9": "(A9 | -A8)",
        "prover9_expression": "(submits_application(CompanyZ, FDA) | -receives_approval(CompanyZ, FDA))",
        "natural": "CompanyZ submits an application to the FDA or CompanyZ does not receive approval from the FDA."
      },
      "(¬(A1 ∨ A2) → A42)": {
        "formal": "(¬(A1 ∨ A2) → A42)",
        "prover9": "(-(A1 | A2) -> A42)",
        "prover9_expression": "(-(develops_cure(CompanyX, DiseaseAlpha) | develops_cure(CompanyY, DiseaseAlpha)) -> forms_consortium(CompanyX, CompanyY))",
        "natural": "If it is not the case that either CompanyX develops a cure for DiseaseAlpha or CompanyY develops a cure for DiseaseAlpha, then CompanyX forms a consortium with CompanyY."
      },
      "(¬(A1 ∨ A2) → A43)": {
        "formal": "(¬(A1 ∨ A2) → A43)",
        "prover9": "(-(A1 | A2) -> A43)",
        "prover9_expression": "(-(develops_cure(CompanyX, DiseaseAlpha) | develops_cure(CompanyY, DiseaseAlpha)) -> forms_consortium(CompanyY, CompanyX))",
        "natural": "Provided that it is not the case that either CompanyX develops a cure for DiseaseAlpha or CompanyY develops a cure for DiseaseAlpha, CompanyY forms a consortium with CompanyX."
      },
      "(¬(A1 ∨ A2) → ¬A42)": {
        "formal": "(¬(A1 ∨ A2) → ¬A42)",
        "prover9": "(-(A1 | A2) -> -A42)",
        "prover9_expression": "(-(develops_cure(CompanyX, DiseaseAlpha) | develops_cure(CompanyY, DiseaseAlpha)) -> -forms_consortium(CompanyX, CompanyY))",
        "natural": "If it is not the case that either CompanyX develops a cure for DiseaseAlpha or CompanyY develops a cure for DiseaseAlpha, then CompanyX does not form a consortium with CompanyY."
      },
      "(¬(A20 ∨ G) → A21)": {
        "formal": "(¬(A20 ∨ G) → A21)",
        "prover9": "(-(A20 | G) -> A21)",
        "prover9_expression": "(-(achieves_breakthrough(ResearcherA) | successful_treatment(DiseaseAlpha)) -> receives_recognition(ResearcherA))",
        "natural": "Under the condition that it is not the case that either ResearcherA achieves a breakthrough or DiseaseAlpha has a successful treatment, ResearcherA receives recognition."
      },
      "(¬(A20 ∨ G) → A22)": {
        "formal": "(¬(A20 ∨ G) → A22)",
        "prover9": "(-(A20 | G) -> A22)",
        "prover9_expression": "(-(achieves_breakthrough(ResearcherA) | successful_treatment(DiseaseAlpha)) -> receives_award(ResearcherA))",
        "natural": "If it is not the case that either ResearcherA achieves a breakthrough or DiseaseAlpha has a successful treatment, then ResearcherA receives an award."
      },
      "(¬(A20 ∨ G) → ¬A21)": {
        "formal": "(¬(A20 ∨ G) → ¬A21)",
        "prover9": "(-(A20 | G) -> -A21)",
        "prover9_expression": "(-(achieves_breakthrough(ResearcherA) | successful_treatment(DiseaseAlpha)) -> -receives_recognition(ResearcherA))",
        "natural": "Provided that it is not the case that either ResearcherA achieves a breakthrough or DiseaseAlpha has a successful treatment, ResearcherA does not receive recognition."
      },
      "(¬(A29 → A27) → A30)": {
        "formal": "(¬(A29 → A27) → A30)",
        "prover9": "(-(A29 -> A27) -> A30)",
        "prover9_expression": "(-(obtains_ethics_approval(InstituteN) -> initiates_trial(InstituteN, DiseaseAlpha)) -> faces_ethical_issues(InstituteM))",
        "natural": "If it is not the case that InstituteN obtaining ethics approval implies that InstituteN initiates a trial for DiseaseAlpha, then InstituteM faces ethical issues."
      },
      "(¬(A36 ∨ A37) → A38)": {
        "formal": "(¬(A36 ∨ A37) → A38)",
        "prover9": "(-(A36 | A37) -> A38)",
        "prover9_expression": "(-(conducts_preclinical(CompanyX, SubstanceGamma) | conducts_preclinical(CompanyY, SubstanceGamma)) -> halts_development(CompanyX, SubstanceGamma))",
        "natural": "Under the condition that it is not the case that either CompanyX conducts preclinical studies on SubstanceGamma or CompanyY conducts preclinical studies on SubstanceGamma, CompanyX halts development of SubstanceGamma."
      },
      "(¬(A36 ∨ A37) → A39)": {
        "formal": "(¬(A36 ∨ A37) → A39)",
        "prover9": "(-(A36 | A37) -> A39)",
        "prover9_expression": "(-(conducts_preclinical(CompanyX, SubstanceGamma) | conducts_preclinical(CompanyY, SubstanceGamma)) -> halts_development(CompanyY, SubstanceGamma))",
        "natural": "If it is not the case that either CompanyX conducts preclinical studies on SubstanceGamma or CompanyY conducts preclinical studies on SubstanceGamma, then CompanyY halts development of SubstanceGamma."
      },
      "(¬(A43 → A42) → A44)": {
        "formal": "(¬(A43 → A42) → A44)",
        "prover9": "(-(A43 -> A42) -> A44)",
        "prover9_expression": "(-(forms_consortium(CompanyY, CompanyX) -> forms_consortium(CompanyX, CompanyY)) -> dissolves_partnership(CompanyX, CompanyY))",
        "natural": "Provided that it is not the case that CompanyY forming a consortium with CompanyX implies that CompanyX forms a consortium with CompanyY, CompanyX dissolves its partnership with CompanyY."
      },
      "(¬(A43 → A42) → A45)": {
        "formal": "(¬(A43 → A42) → A45)",
        "prover9": "(-(A43 -> A42) -> A45)",
        "prover9_expression": "(-(forms_consortium(CompanyY, CompanyX) -> forms_consortium(CompanyX, CompanyY)) -> dissolves_partnership(CompanyY, CompanyX))",
        "natural": "If it is not the case that CompanyY forming a consortium with CompanyX implies that CompanyX forms a consortium with CompanyY, then CompanyY dissolves its partnership with CompanyX."
      },
      "(¬(A43 → A42) → ¬A44)": {
        "formal": "(¬(A43 → A42) → ¬A44)",
        "prover9": "(-(A43 -> A42) -> -A44)",
        "prover9_expression": "(-(forms_consortium(CompanyY, CompanyX) -> forms_consortium(CompanyX, CompanyY)) -> -dissolves_partnership(CompanyX, CompanyY))",
        "natural": "Under the condition that it is not the case that CompanyY forming a consortium with CompanyX implies that CompanyX forms a consortium with CompanyY, CompanyX does not dissolve its partnership with CompanyY."
      },
      "(¬(A45 → ¬A44) → A46)": {
        "formal": "(¬(A45 → ¬A44) → A46)",
        "prover9": "(-(A45 -> -A44) -> A46)",
        "prover9_expression": "(-(dissolves_partnership(CompanyY, CompanyX) -> -dissolves_partnership(CompanyX, CompanyY)) -> seeks_mediation(CompanyX, CompanyY))",
        "natural": "If it is not the case that CompanyY dissolving its partnership with CompanyX implies that CompanyX does not dissolve its partnership with CompanyY, then CompanyX seeks mediation with CompanyY."
      },
      "(¬(A45 → ¬A44) → ¬A46)": {
        "formal": "(¬(A45 → ¬A44) → ¬A46)",
        "prover9": "(-(A45 -> -A44) -> -A46)",
        "prover9_expression": "(-(dissolves_partnership(CompanyY, CompanyX) -> -dissolves_partnership(CompanyX, CompanyY)) -> -seeks_mediation(CompanyX, CompanyY))",
        "natural": "Provided that it is not the case that CompanyY dissolving its partnership with CompanyX implies that CompanyX does not dissolve its partnership with CompanyY, CompanyX does not seek mediation with CompanyY."
      },
      "(¬(A56 → ¬A17) → A57)": {
        "formal": "(¬(A56 → ¬A17) → A57)",
        "prover9": "(-(A56 -> -A17) -> A57)",
        "prover9_expression": "(-(challenges_patent(CompanyZ, CompanyX) -> -licenses_technology(CompanyY, CompanyX)) -> loses_lawsuit(CompanyY))",
        "natural": "Under the condition that it is not the case that CompanyZ challenging CompanyX's patent implies that CompanyY does not license technology from CompanyX, CompanyY loses a lawsuit."
      },
      "(¬(A56 → ¬A17) → ¬A57)": {
        "formal": "(¬(A56 → ¬A17) → ¬A57)",
        "prover9": "(-(A56 -> -A17) -> -A57)",
        "prover9_expression": "(-(challenges_patent(CompanyZ, CompanyX) -> -licenses_technology(CompanyY, CompanyX)) -> -loses_lawsuit(CompanyY))",
        "natural": "If it is not the case that CompanyZ challenging CompanyX's patent implies that CompanyY does not license technology from CompanyX, then CompanyY does not lose a lawsuit."
      },
      "(¬(A59 ∨ A60) → A61)": {
        "formal": "(¬(A59 ∨ A60) → A61)",
        "prover9": "(-(A59 | A60) -> A61)",
        "prover9_expression": "(-(appeals_decision(CompanyY) | appeals_decision(CompanyZ)) -> accepts_ruling(CompanyY))",
        "natural": "Provided that it is not the case that either CompanyY appeals the decision or CompanyZ appeals the decision, CompanyY accepts the ruling."
      },
      "(¬(A59 ∨ A60) → ¬A61)": {
        "formal": "(¬(A59 ∨ A60) → ¬A61)",
        "prover9": "(-(A59 | A60) -> -A61)",
        "prover9_expression": "(-(appeals_decision(CompanyY) | appeals_decision(CompanyZ)) -> -accepts_ruling(CompanyY))",
        "natural": "If it is not the case that either CompanyY appeals the decision or CompanyZ appeals the decision, then CompanyY does not accept the ruling."
      },
      "(¬(¬(A45 → ¬A44) → A46) → A47)": {
        "formal": "(¬(¬(A45 → ¬A44) → A46) → A47)",
        "prover9": "(-(-(A45 -> -A44) -> A46) -> A47)",
        "prover9_expression": "(-(-(dissolves_partnership(CompanyY, CompanyX) -> -dissolves_partnership(CompanyX, CompanyY)) -> seeks_mediation(CompanyX, CompanyY)) -> reaches_settlement(CompanyX, CompanyY))",
        "natural": "Under the condition that it is not the case that CompanyY dissolving its partnership with CompanyX not implying that CompanyX does not dissolve its partnership with CompanyY implies that CompanyX seeks mediation with CompanyY, CompanyX and CompanyY reach a settlement."
      },
      "(¬(¬(A45 → ¬A44) → A46) → ¬A47)": {
        "formal": "(¬(¬(A45 → ¬A44) → A46) → ¬A47)",
        "prover9": "(-(-(A45 -> -A44) -> A46) -> -A47)",
        "prover9_expression": "(-(-(dissolves_partnership(CompanyY, CompanyX) -> -dissolves_partnership(CompanyX, CompanyY)) -> seeks_mediation(CompanyX, CompanyY)) -> -reaches_settlement(CompanyX, CompanyY))",
        "natural": "If it is not the case that CompanyY dissolving its partnership with CompanyX not implying that CompanyX does not dissolve its partnership with CompanyY implies that CompanyX seeks mediation with CompanyY, then CompanyX and CompanyY do not reach a settlement."
      },
      "(¬(¬(A56 → ¬A17) → ¬A57) → A58)": {
        "formal": "(¬(¬(A56 → ¬A17) → ¬A57) → A58)",
        "prover9": "(-(-(A56 -> -A17) -> -A57) -> A58)",
        "prover9_expression": "(-(-(challenges_patent(CompanyZ, CompanyX) -> -licenses_technology(CompanyY, CompanyX)) -> -loses_lawsuit(CompanyY)) -> wins_lawsuit(CompanyX))",
        "natural": "Provided that it is not the case that CompanyZ challenging CompanyX's patent not implying that CompanyY does not license technology from CompanyX implies that CompanyY does not lose a lawsuit, CompanyX wins a lawsuit."
      },
      "(¬(¬(A56 → ¬A17) → ¬A57) → ¬A58)": {
        "formal": "(¬(¬(A56 → ¬A17) → ¬A57) → ¬A58)",
        "prover9": "(-(-(A56 -> -A17) -> -A57) -> -A58)",
        "prover9_expression": "(-(-(challenges_patent(CompanyZ, CompanyX) -> -licenses_technology(CompanyY, CompanyX)) -> -loses_lawsuit(CompanyY)) -> -wins_lawsuit(CompanyX))",
        "natural": "Under the condition that it is not the case that CompanyZ challenging CompanyX's patent not implying that CompanyY does not license technology from CompanyX implies that CompanyY does not lose a lawsuit, CompanyX does not win a lawsuit."
      },
      "(¬(¬(¬(A45 → ¬A44) → A46) → ¬A47) → A48)": {
        "formal": "(¬(¬(¬(A45 → ¬A44) → A46) → ¬A47) → A48)",
        "prover9": "(-(-(-(A45 -> -A44) -> A46) -> -A47) -> A48)",
        "prover9_expression": "(-(-(-(dissolves_partnership(CompanyY, CompanyX) -> -dissolves_partnership(CompanyX, CompanyY)) -> seeks_mediation(CompanyX, CompanyY)) -> -reaches_settlement(CompanyX, CompanyY)) -> renews_collaboration(CompanyX, CompanyY))",
        "natural": "If it is not the case that CompanyY dissolving its partnership with CompanyX not implying that CompanyX does not dissolve its partnership with CompanyY not implying that CompanyX seeks mediation with CompanyY implies that CompanyX and CompanyY do not reach a settlement, then CompanyX renews collaboration with CompanyY."
      },
      "(¬A13 → A14)": {
        "formal": "(¬A13 → A14)",
        "prover9": "(-A13 -> A14)",
        "prover9_expression": "(-discovers_mechanism(ResearcherA, SubstanceGamma) -> develops_resistance(DiseaseAlpha, TreatmentBeta))",
        "natural": "If ResearcherA does not discover the mechanism of SubstanceGamma, then DiseaseAlpha develops resistance to TreatmentBeta."
      },
      "(¬A16 → A17)": {
        "formal": "(¬A16 → A17)",
        "prover9": "(-A16 -> A17)",
        "prover9_expression": "(-secures_patent(CompanyX, SubstanceGamma) -> licenses_technology(CompanyY, CompanyX))",
        "natural": "Under the condition that CompanyX does not secure a patent for SubstanceGamma, CompanyY licenses technology from CompanyX."
      },
      "(¬G → A10)": {
        "formal": "(¬G → A10)",
        "prover9": "(-G -> A10)",
        "prover9_expression": "(-successful_treatment(DiseaseAlpha) -> experiences_setback(CompanyX, ClinicalTrial))",
        "natural": "Provided that DiseaseAlpha does not have a successful treatment, CompanyX experiences a setback in a clinical trial."
      },
      "A11": {
        "formal": "A11",
        "prover9": "A11",
        "prover9_expression": "publishes_paper(ResearcherA, JournalScience)",
        "natural": "ResearcherA publishes a paper in JournalScience."
      },
      "A13": {
        "formal": "A13",
        "prover9": "A13",
        "prover9_expression": "discovers_mechanism(ResearcherA, SubstanceGamma)",
        "natural": "ResearcherA discovers the mechanism of SubstanceGamma."
      },
      "A16": {
        "formal": "A16",
        "prover9": "A16",
        "prover9_expression": "secures_patent(CompanyX, SubstanceGamma)",
        "natural": "CompanyX secures a patent for SubstanceGamma."
      },
      "A19": {
        "formal": "A19",
        "prover9": "A19",
        "prover9_expression": "protects_patent(CompanyX)",
        "natural": "CompanyX protects its patent."
      },
      "A7": {
        "formal": "A7",
        "prover9": "A7",
        "prover9_expression": "applies_for_grant(CompanyZ, GrantOne)",
        "natural": "CompanyZ applies for GrantOne."
      },
      "G": {
        "formal": "G",
        "prover9": "G",
        "prover9_expression": "successful_treatment(DiseaseAlpha)",
        "natural": "DiseaseAlpha has a successful treatment."
      },
      "¬A10": {
        "formal": "¬A10",
        "prover9": "-A10",
        "prover9_expression": "-experiences_setback(CompanyX, ClinicalTrial)",
        "natural": "CompanyX does not experience a setback in a clinical trial."
      },
      "¬A12": {
        "formal": "¬A12",
        "prover9": "-A12",
        "prover9_expression": "-publishes_paper(ResearcherB, JournalNature)",
        "natural": "ResearcherB does not publish a paper in JournalNature."
      },
      "¬A14": {
        "formal": "¬A14",
        "prover9": "-A14",
        "prover9_expression": "-develops_resistance(DiseaseAlpha, TreatmentBeta)",
        "natural": "DiseaseAlpha does not develop resistance to TreatmentBeta."
      },
      "¬A15": {
        "formal": "¬A15",
        "prover9": "-A15",
        "prover9_expression": "-requires_new_treatment(DiseaseAlpha)",
        "natural": "DiseaseAlpha does not require a new treatment."
      },
      "¬A17": {
        "formal": "¬A17",
        "prover9": "-A17",
        "prover9_expression": "-licenses_technology(CompanyY, CompanyX)",
        "natural": "CompanyY does not license technology from CompanyX."
      },
      "¬A18": {
        "formal": "¬A18",
        "prover9": "-A18",
        "prover9_expression": "-shares_intellectual_property(CompanyX, CompanyY)",
        "natural": "CompanyX does not share intellectual property with CompanyY."
      },
      "¬A20": {
        "formal": "¬A20",
        "prover9": "-A20",
        "prover9_expression": "-achieves_breakthrough(ResearcherA)",
        "natural": "ResearcherA does not achieve a breakthrough."
      },
      "¬A23": {
        "formal": "¬A23",
        "prover9": "-A23",
        "prover9_expression": "-collaborates(ResearcherA, ResearcherB)",
        "natural": "ResearcherA does not collaborate with ResearcherB."
      },
      "¬A30": {
        "formal": "¬A30",
        "prover9": "-A30",
        "prover9_expression": "-faces_ethical_issues(InstituteM)",
        "natural": "InstituteM does not face ethical issues."
      },
      "¬A33": {
        "formal": "¬A33",
        "prover9": "-A33",
        "prover9_expression": "-shows_efficacy(SubstanceGamma, DiseaseAlpha)",
        "natural": "SubstanceGamma does not show efficacy against DiseaseAlpha."
      },
      "¬A34": {
        "formal": "¬A34",
        "prover9": "-A34",
        "prover9_expression": "-shows_toxicity(SubstanceGamma)",
        "natural": "SubstanceGamma does not show toxicity."
      },
      "¬A38": {
        "formal": "¬A38",
        "prover9": "-A38",
        "prover9_expression": "-halts_development(CompanyX, SubstanceGamma)",
        "natural": "CompanyX does not halt development of SubstanceGamma."
      },
      "¬A40": {
        "formal": "¬A40",
        "prover9": "-A40",
        "prover9_expression": "-continues_research(CompanyX)",
        "natural": "CompanyX does not continue research."
      },
      "¬A41": {
        "formal": "¬A41",
        "prover9": "-A41",
        "prover9_expression": "-continues_research(CompanyY)",
        "natural": "CompanyY does not continue research."
      },
      "¬A48": {
        "formal": "¬A48",
        "prover9": "-A48",
        "prover9_expression": "-renews_collaboration(CompanyX, CompanyY)",
        "natural": "CompanyX does not renew collaboration with CompanyY."
      },
      "¬A5": {
        "formal": "¬A5",
        "prover9": "-A5",
        "prover9_expression": "-receives_funding(CompanyX, GrantOne)",
        "natural": "CompanyX does not receive funding from GrantOne."
      },
      "¬A6": {
        "formal": "¬A6",
        "prover9": "-A6",
        "prover9_expression": "-receives_funding(CompanyY, GrantOne)",
        "natural": "CompanyY does not receive funding from GrantOne."
      },
      "¬A8": {
        "formal": "¬A8",
        "prover9": "-A8",
        "prover9_expression": "-receives_approval(CompanyZ, FDA)",
        "natural": "CompanyZ does not receive approval from the FDA."
      },
      "¬A9": {
        "formal": "¬A9",
        "prover9": "-A9",
        "prover9_expression": "-submits_application(CompanyZ, FDA)",
        "natural": "CompanyZ does not submit an application to the FDA."
      }
    }
  }
}